Eicosanoid signalling pathways in the development and progression of colorectal cancer: novel approaches for prevention/intervention
Arachidonic acid metabolism through cyclooxygenase (COX), lipoxygenase (LOX) and cytochrome P -450 epoxygenase (EPOX) pathways leads to the generation of biologically active eicosanoids, including prostanoids, leukotrienes, hydroxyeicosatetraenoic acid, epoxyeicosatrienoic acid and hydroperoxyeicosa...
Saved in:
| Published in | Cancer and metastasis reviews Vol. 30; no. 3-4; pp. 363 - 385 |
|---|---|
| Main Authors | , , |
| Format | Journal Article |
| Language | English |
| Published |
Boston
Springer US
01.12.2011
Springer Springer Nature B.V |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Arachidonic acid metabolism through cyclooxygenase (COX), lipoxygenase (LOX) and cytochrome
P
-450 epoxygenase (EPOX) pathways leads to the generation of biologically active eicosanoids, including prostanoids, leukotrienes, hydroxyeicosatetraenoic acid, epoxyeicosatrienoic acid and hydroperoxyeicosatetraenoic acids. Eicosanoid expression levels vary during tumor development and progression of a range of malignancies, including colorectal cancer. The actions of these autocoids are also directly influenced by diet, as demonstrated by recent evidence for omega-3 fatty acids in colorectal cancer (CRC) prevention and/or treatment. Eicosanoids regulate CRC development and progression, while inhibition of these pathways has generally been shown to inhibit tumor growth/progression. A progressive sequence of colorectal cancer development has been identified, ranging from normal colon, to colitis, dysplasia, and carcinoma. While both COX and LOX inhibition are both promising candidates for colorectal cancer prevention and/or treatment, there is an urgent need to understand the mechanisms through which these signalling pathways mediate their effects on tumorigenesis. This will allow identification of safer, more effective strategies for colorectal cancer prevention and/or treatment. In particular, binding to/signalling through prostanoid receptors have recently been the subject of considerable interest in this area. In this review, we discuss the role of the eicosanoid signalling pathways in the development and progression of colorectal cancer. We discuss the effects of the eicosanoids on tumor cell proliferation, their roles in cell death induction, effects on angiogenesis, migration, invasion and their regulation of the immune response. Signal transduction pathways involved in these processes are also discussed. Finally, novel approaches targeting these arachidonic acid-derived eicosanoids (using pharmacological or natural agents) for chemoprevention and/or treatment of colorectal cancer are outlined. |
|---|---|
| AbstractList | Issue Title: Bioactive Lipids in Cancer and Inflammation Arachidonic acid metabolism through cyclooxygenase (COX), lipoxygenase (LOX) and cytochrome P-450 epoxygenase (EPOX) pathways leads to the generation of biologically active eicosanoids, including prostanoids, leukotrienes, hydroxyeicosatetraenoic acid, epoxyeicosatrienoic acid and hydroperoxyeicosatetraenoic acids. Eicosanoid expression levels vary during tumor development and progression of a range of malignancies, including colorectal cancer. The actions of these autocoids are also directly influenced by diet, as demonstrated by recent evidence for omega-3 fatty acids in colorectal cancer (CRC) prevention and/or treatment. Eicosanoids regulate CRC development and progression, while inhibition of these pathways has generally been shown to inhibit tumor growth/progression. A progressive sequence of colorectal cancer development has been identified, ranging from normal colon, to colitis, dysplasia, and carcinoma. While both COX and LOX inhibition are both promising candidates for colorectal cancer prevention and/or treatment, there is an urgent need to understand the mechanisms through which these signalling pathways mediate their effects on tumorigenesis. This will allow identification of safer, more effective strategies for colorectal cancer prevention and/or treatment. In particular, binding to/signalling through prostanoid receptors have recently been the subject of considerable interest in this area. In this review, we discuss the role of the eicosanoid signalling pathways in the development and progression of colorectal cancer. We discuss the effects of the eicosanoids on tumor cell proliferation, their roles in cell death induction, effects on angiogenesis, migration, invasion and their regulation of the immune response. Signal transduction pathways involved in these processes are also discussed. Finally, novel approaches targeting these arachidonic acid-derived eicosanoids (using pharmacological or natural agents) for chemoprevention and/or treatment of colorectal cancer are outlined.[PUBLICATION ABSTRACT] Arachidonic acid metabolism through cyclooxygenase (COX), lipoxygenase (LOX) and cytochrome P-450 epoxygenase (EPOX) pathways leads to the generation of biologically active eicosanoids, including prostanoids, leukotrienes, hydroxyeicosatetraenoic acid, epoxyeicosatrienoic acid and hydroperoxyeicosatetraenoic acids. Eicosanoid expression levels vary during tumor development and progression of a range of malignancies, including colorectal cancer. The actions of these autocoids are also directly influenced by diet, as demonstrated by recent evidence for omega-3 fatty acids in colorectal cancer (CRC) prevention and/or treatment. Eicosanoids regulate CRC development and progression, while inhibition of these pathways has generally been shown to inhibit tumor growth/progression. A progressive sequence of colorectal cancer development has been identified, ranging from normal colon, to colitis, dysplasia, and carcinoma. While both COX and LOX inhibition are both promising candidates for colorectal cancer prevention and/or treatment, there is an urgent need to understand the mechanisms through which these signalling pathways mediate their effects on tumorigenesis. This will allow identification of safer, more effective strategies for colorectal cancer prevention and/or treatment. In particular, binding to/signalling through prostanoid receptors have recently been the subject of considerable interest in this area. In this review, we discuss the role of the eicosanoid signalling pathways in the development and progression of colorectal cancer. We discuss the effects of the eicosanoids on tumor cell proliferation, their roles in cell death induction, effects on angiogenesis, migration, invasion and their regulation of the immune response. Signal transduction pathways involved in these processes are also discussed. Finally, novel approaches targeting these arachidonic acid-derived eicosanoids (using pharmacological or natural agents) for chemoprevention and/or treatment of colorectal cancer are outlined.Arachidonic acid metabolism through cyclooxygenase (COX), lipoxygenase (LOX) and cytochrome P-450 epoxygenase (EPOX) pathways leads to the generation of biologically active eicosanoids, including prostanoids, leukotrienes, hydroxyeicosatetraenoic acid, epoxyeicosatrienoic acid and hydroperoxyeicosatetraenoic acids. Eicosanoid expression levels vary during tumor development and progression of a range of malignancies, including colorectal cancer. The actions of these autocoids are also directly influenced by diet, as demonstrated by recent evidence for omega-3 fatty acids in colorectal cancer (CRC) prevention and/or treatment. Eicosanoids regulate CRC development and progression, while inhibition of these pathways has generally been shown to inhibit tumor growth/progression. A progressive sequence of colorectal cancer development has been identified, ranging from normal colon, to colitis, dysplasia, and carcinoma. While both COX and LOX inhibition are both promising candidates for colorectal cancer prevention and/or treatment, there is an urgent need to understand the mechanisms through which these signalling pathways mediate their effects on tumorigenesis. This will allow identification of safer, more effective strategies for colorectal cancer prevention and/or treatment. In particular, binding to/signalling through prostanoid receptors have recently been the subject of considerable interest in this area. In this review, we discuss the role of the eicosanoid signalling pathways in the development and progression of colorectal cancer. We discuss the effects of the eicosanoids on tumor cell proliferation, their roles in cell death induction, effects on angiogenesis, migration, invasion and their regulation of the immune response. Signal transduction pathways involved in these processes are also discussed. Finally, novel approaches targeting these arachidonic acid-derived eicosanoids (using pharmacological or natural agents) for chemoprevention and/or treatment of colorectal cancer are outlined. Arachidonic acid metabolism through cyclooxygenase (COX), lipoxygenase (LOX) and cytochrome P-450 epoxygenase (EPOX) pathways leads to the generation of biologically active eicosanoids, including prostanoids, leukotrienes, hydroxyeicosatetraenoic acid, epoxyeicosatrienoic acid and hydroperoxyeicosatetraenoic acids. Eicosanoid expression levels vary during tumor development and progression of a range of malignancies, including colorectal cancer. The actions of these autocoids are also directly influenced by diet, as demonstrated by recent evidence for omega-3 fatty acids in colorectal cancer (CRC) prevention and/or treatment. Eicosanoids regulate CRC development and progression, while inhibition of these pathways has generally been shown to inhibit tumor growth/progression. A progressive sequence of colorectal cancer development has been identified, ranging from normal colon, to colitis, dysplasia, and carcinoma. While both COX and LOX inhibition are both promising candidates for colorectal cancer prevention and/or treatment, there is an urgent need to understand the mechanisms through which these signalling pathways mediate their effects on tumorigenesis. This will allow identification of safer, more effective strategies for colorectal cancer prevention and/or treatment. In particular, binding to/signalling through prostanoid receptors have recently been the subject of considerable interest in this area. In this review, we discuss the role of the eicosanoid signalling pathways in the development and progression of colorectal cancer. We discuss the effects of the eicosanoids on tumor cell proliferation, their roles in cell death induction, effects on angiogenesis, migration, invasion and their regulation of the immune response. Signal transduction pathways involved in these processes are also discussed. Finally, novel approaches targeting these arachidonic acid-derived eicosanoids (using pharmacological or natural agents) for chemoprevention and/or treatment of colorectal cancer are outlined. Arachidonic acid metabolism through cyclooxygenase (COX), lipoxygenase (LOX) and cytochrome P -450 epoxygenase (EPOX) pathways leads to the generation of biologically active eicosanoids, including prostanoids, leukotrienes, hydroxyeicosatetraenoic acid, epoxyeicosatrienoic acid and hydroperoxyeicosatetraenoic acids. Eicosanoid expression levels vary during tumor development and progression of a range of malignancies, including colorectal cancer. The actions of these autocoids are also directly influenced by diet, as demonstrated by recent evidence for omega-3 fatty acids in colorectal cancer (CRC) prevention and/or treatment. Eicosanoids regulate CRC development and progression, while inhibition of these pathways has generally been shown to inhibit tumor growth/progression. A progressive sequence of colorectal cancer development has been identified, ranging from normal colon, to colitis, dysplasia, and carcinoma. While both COX and LOX inhibition are both promising candidates for colorectal cancer prevention and/or treatment, there is an urgent need to understand the mechanisms through which these signalling pathways mediate their effects on tumorigenesis. This will allow identification of safer, more effective strategies for colorectal cancer prevention and/or treatment. In particular, binding to/signalling through prostanoid receptors have recently been the subject of considerable interest in this area. In this review, we discuss the role of the eicosanoid signalling pathways in the development and progression of colorectal cancer. We discuss the effects of the eicosanoids on tumor cell proliferation, their roles in cell death induction, effects on angiogenesis, migration, invasion and their regulation of the immune response. Signal transduction pathways involved in these processes are also discussed. Finally, novel approaches targeting these arachidonic acid-derived eicosanoids (using pharmacological or natural agents) for chemoprevention and/or treatment of colorectal cancer are outlined. |
| Audience | Academic |
| Author | Cathcart, Mary-Clare Pidgeon, Graham P. Lysaght, Joanne |
| Author_xml | – sequence: 1 givenname: Mary-Clare surname: Cathcart fullname: Cathcart, Mary-Clare email: cathcarm@tcd.ie organization: Department of Surgery, Institute of Molecular Medicine, Trinity Health Sciences Centre, St. James’s Hospital, Trinity College Dublin – sequence: 2 givenname: Joanne surname: Lysaght fullname: Lysaght, Joanne organization: Department of Surgery, Institute of Molecular Medicine, Trinity Health Sciences Centre, St. James’s Hospital, Trinity College Dublin – sequence: 3 givenname: Graham P. surname: Pidgeon fullname: Pidgeon, Graham P. organization: Department of Surgery, Institute of Molecular Medicine, Trinity Health Sciences Centre, St. James’s Hospital, Trinity College Dublin |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/22134655$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kk1v1DAQhi1URLcLP4ALsuDAKa0dx8mGW1WVD6kSFzhbE3uSdeW1UzsL7Z0fjqNsVVoB8sGy9TyvRjNzQo588EjIa85OOWPNWeJMSlkwzotWlFVx-4ysuGxE0ZRCHJEV43VTNLVsj8lJStcsO6JpX5DjsuSiqqVckV-XVocEPlhDkx08OGf9QEeYtj_hLlHr6bRFavAHujDu0E8UvKFjDEPElGzwNPRUBxci6gkc1eA1xg_Uh2xQGDMJeouJ9iFmLef4KVtn1k8YD4-X5HkPLuGrw70m3z9efrv4XFx9_fTl4vyq0FVdTYXueMdrBlAzXm5AimajgQkhOwRkKGsh-3qjDYJskWkDra40dmVXmV5rY8SavF9yc1E3e0yT2tmk0TnwGPZJtZy3VcVz5Jq8fUJeh33M3ZkhtmFtXTUZerdAAzhU1vdhiqDnSHXe8HJm2voh6hGlR3uj_oRO_wLlY3CXB-Sxt_n_UeqbQ4H7bodGjdHuIN6p-8lmoFkAHUNKEXul7QRzt3OydYozNe-QWnZI5R1S8w6p22zyJ-Z9-P-ccnFSZv2A8aFf_5Z-A4B22sk |
| CODEN | CMRED4 |
| CitedBy_id | crossref_primary_10_1016_j_medj_2024_05_002 crossref_primary_10_1007_s00424_024_02960_x crossref_primary_10_1016_j_toxicon_2024_108120 crossref_primary_10_1038_s41698_017_0040_z crossref_primary_10_3389_fphar_2025_1500511 crossref_primary_10_1093_advances_nmaa104 crossref_primary_10_1016_j_ejphar_2016_12_004 crossref_primary_10_1016_j_prp_2014_06_016 crossref_primary_10_5493_wjem_v2_i4_78 crossref_primary_10_1371_journal_pone_0073466 crossref_primary_10_3748_wjg_v21_i41_11748 crossref_primary_10_1016_j_freeradbiomed_2017_01_017 crossref_primary_10_1016_j_jchromb_2014_05_024 crossref_primary_10_3389_fphar_2021_806395 crossref_primary_10_1016_j_heliyon_2024_e35265 crossref_primary_10_1016_j_humpath_2018_11_013 crossref_primary_10_1517_14728222_2016_1139085 crossref_primary_10_1016_j_plefa_2014_09_001 crossref_primary_10_1111_cns_12596 crossref_primary_10_1155_2013_834684 crossref_primary_10_1007_s10555_018_9739_8 crossref_primary_10_1016_j_plefa_2015_04_009 crossref_primary_10_2217_fon_15_235 crossref_primary_10_3748_wjg_v25_i23_2863 crossref_primary_10_1016_j_prostaglandins_2014_07_002 crossref_primary_10_3109_09553002_2013_784426 crossref_primary_10_1155_2013_416534 crossref_primary_10_1016_j_humpath_2012_07_003 crossref_primary_10_1016_j_prostaglandins_2012_12_002 crossref_primary_10_1038_s41598_017_08433_9 crossref_primary_10_1007_s00011_023_01770_8 crossref_primary_10_1016_j_lfs_2012_10_025 crossref_primary_10_1016_j_plefa_2018_05_002 crossref_primary_10_3748_wjg_v20_i48_18151 crossref_primary_10_3390_ijms24021353 crossref_primary_10_3945_jn_114_208462 crossref_primary_10_1152_ajpgi_00064_2014 crossref_primary_10_1002_mco2_27 crossref_primary_10_1007_s10555_018_9743_z crossref_primary_10_1016_j_redox_2013_11_001 crossref_primary_10_1002_cam4_3051 crossref_primary_10_1016_j_yexcr_2013_10_021 crossref_primary_10_3389_fphar_2020_00533 crossref_primary_10_18632_oncotarget_16718 crossref_primary_10_1016_j_canlet_2017_05_002 crossref_primary_10_1016_j_prostaglandins_2017_08_010 crossref_primary_10_18632_oncotarget_19173 crossref_primary_10_1016_j_jnutbio_2017_06_006 crossref_primary_10_1007_s13668_012_0023_1 crossref_primary_10_1371_journal_pone_0121402 crossref_primary_10_3389_fphar_2022_889181 crossref_primary_10_1016_j_bbalip_2014_10_002 crossref_primary_10_1007_s11306_017_1293_9 crossref_primary_10_2147_OTT_S251965 crossref_primary_10_1016_j_bbalip_2017_01_003 crossref_primary_10_1186_s13148_015_0110_4 crossref_primary_10_3389_fphar_2020_595498 crossref_primary_10_1007_s10555_013_9444_6 crossref_primary_10_1016_j_prostaglandins_2015_12_007 crossref_primary_10_1038_s12276_018_0150_x |
| Cites_doi | 10.1002/rcm.4926 10.1593/neo.10388 10.1038/onc.2011.472 10.1016/S0140-6736(98)05095-8 10.4049/jimmunol.175.3.1483 10.1038/onc.2009.421 10.1126/science.1116221 10.1016/j.yexcr.2007.06.004 10.1074/jbc.271.7.3460 10.1046/j.1365-2249.1999.01017.x 10.1158/1078-0432.CCR-05-0171 10.1038/nrc2809 10.1111/j.1443-9573.2007.00290.x 10.1254/jphs.FP0060651 10.1038/sj.onc.1208883 10.1073/pnas.94.9.4312 10.1158/1078-0432.CCR-07-4631 10.1084/jem.20052124 10.1016/S0092-8674(00)81683-9 10.1172/JCI117620 10.1038/nrgastro.2009.44 10.1093/carcin/bgi012 10.2174/0929867003374282 10.1016/0016-5085(94)90246-1 10.1093/carcin/bgg033 10.1056/NEJMoa050405 10.1038/nrc1093 10.1111/j.1538-7836.2009.03396.x 10.1136/gut.2009.203000 10.1207/S15327914NC4602_10 10.1007/s003940050054 10.1016/j.cdp.2004.12.001 10.1158/1078-0432.CCR-09-2301 10.1093/jn/130.5.1153 10.1053/gast.2001.29691 10.1080/02841860701403061 10.1021/jf071004r 10.1097/00000658-200102000-00006 10.1007/BF02484622 10.1016/S0006-291X(02)02014-4 10.1016/j.plefa.2008.09.024 10.1016/j.prostaglandins.2011.08.004 10.1056/NEJMoa050493 10.1158/0008-5472.CAN-09-2105 10.1016/S0962-8924(98)80005-6 10.1056/NEJMoa061355 10.1074/jbc.M302474200 10.1093/carcin/bgh265 10.1038/359235a0 10.1002/ijc.22755 10.1093/eurheartj/ehl053 10.1007/3-540-26980-0_14 10.1016/j.ccr.2004.08.011 10.1046/j.1538-7836.2003.00475.x 10.1158/1940-6207.CAPR-08-0099 10.1200/JCO.2009.21.9410 10.1038/261558a0 10.1038/383438a0 10.1016/S0952-3278(03)00110-8 10.1016/j.ejphar.2005.07.009 10.1152/ajpgi.00584.2006 10.1038/nature03357 10.1194/jlr.M600008-JLR200 10.1016/j.humpath.2004.04.001 10.1126/science.294.5548.1871 10.1016/S0952-3278(02)00235-1 10.1038/nri915 10.1007/s00384-007-0407-7 10.1158/0008-5472.CAN-04-3441 10.1016/j.febslet.2006.05.007 10.1073/pnas.94.9.4318 10.1038/35025220 10.1016/S0022-3565(25)24061-7 10.1158/0008-5472.CAN-04-3671 10.1073/pnas.0607948103 10.1016/S0090-4295(99)80198-8 10.1136/bmj.332.7553.1302 10.1155/2008/931074 10.1016/j.plefa.2006.11.008 10.1016/S0079-6603(08)60867-3 10.1158/1078-0432.CCR-08-3101 10.1007/s13277-010-0078-9 10.1517/14728220802653631 10.1007/s10555-007-9098-3 10.1158/1940-6207.CAPR-10-0098 10.1093/jnci/djp078 10.1158/1078-0432.CCR-04-0838 10.1073/pnas.0510562103 10.1172/JCI0214459 10.4049/jimmunol.178.12.8138 10.1158/1535-7163.MCT-08-0498 10.1158/0008-5472.CAN-06-1271 10.1007/s10555-010-9264-x 10.1016/j.prostaglandins.2006.08.005 10.1158/1078-0432.CCR-07-4024 10.1038/nrc1254 10.4049/jimmunol.1001876 10.1016/j.bbrc.2011.06.008 10.1093/carcin/bgh322 10.1038/bjc.1996.332 10.1158/0008-5472.CAN-04-4173 10.1016/j.prostaglandins.2004.01.001 10.1136/gut.50.5.658 10.1084/jem.20021408 10.1158/0008-5472.CAN-06-1787 10.1096/fj.02-1011com 10.1515/DMDI.2000.17.1-4.109 10.2174/156652409788488748 10.1093/carcin/20.10.1985 10.1038/nm0302-289 10.1111/j.1365-2796.2010.02246.x 10.1002/1097-0142(20010215)91:4<737::AID-CNCR1059>3.0.CO;2-F 10.1016/j.bmc.2006.06.045 10.1002/ijc.25516 10.1093/carcin/bgr210 10.1186/1471-230X-10-82 10.1093/ajcn/66.6.1530S 10.1158/0008-5472.CAN-10-1923 10.1093/carcin/bgm256 10.1007/978-1-60327-530-9_16 10.1126/science.7015512 10.1007/s00262-007-0417-x 10.1016/j.prostaglandins.2010.07.002 10.1053/j.gastro.2010.01.058 10.1007/s00384-010-0980-z 10.1158/1940-6207.CAPR-11-0188 10.1056/NEJM200011233432103 10.1016/S0024-3205(02)01510-2 10.1124/jpet.106.101188 10.1016/S0021-9258(17)44821-6 10.1136/gut.2004.059824 10.1038/nm0901-1048 10.1016/j.plefa.2004.10.006 10.1073/pnas.97.24.13275 10.1186/1471-2407-8-380 10.1016/j.prostaglandins.2006.05.022 10.1093/carcin/bgh165 10.1016/j.prostaglandins.2005.10.004 10.1016/S1535-6108(03)00310-6 10.1056/NEJM198809013190901 10.1016/j.bcp.2010.11.001 10.1161/ATVBAHA.110.207449 10.3164/jcbn.09-21 10.1124/dmd.110.035287 10.1158/0008-5472.CAN-11-1262 10.1158/0008-5472.CAN-04-0849 10.1158/1535-7163.MCT-09-0290 10.1016/j.bbrc.2008.05.026 10.1016/S0955-0674(98)80144-0 10.1038/onc.2010.94 10.1002/(SICI)1097-0045(19981101)37:3<161::AID-PROS5>3.0.CO;2-D 10.1136/gut.46.2.191 10.1016/j.fct.2006.08.013 10.1124/jpet.110.173278 10.1016/j.canlet.2008.03.004 10.1124/jpet.107.130336 10.1159/000093551 10.1074/jbc.M110.154971 10.1016/j.canlet.2004.02.023 10.1074/jbc.274.34.23679 10.1007/BF02576790 10.1158/1940-6207.CAPR-09-0110 10.1016/j.cell.2011.02.013 10.1158/0008-5472.CAN-07-6100 10.1158/1535-7163.MCT-06-0318 10.1158/1078-0432.CCR-10-0156 10.1016/j.pharmthera.2004.05.003 10.1172/JCI14869 10.1158/0008-5472.CAN-05-3767 10.1124/jpet.104.068031 10.1126/science.285.5430.1028 10.1016/S0163-7827(03)00049-3 10.1073/pnas.0603235103 10.1046/j.1365-2168.2002.02120.x 10.1042/bj2590315 10.1074/jbc.M411221200 10.1074/jbc.R100030200 10.1016/S0002-9440(10)61216-3 10.1593/neo.04457 10.1097/00042737-200406000-00017 10.1007/BF00053896 10.1074/jbc.M313989200 10.1097/COC.0b013e31815878c9 10.1007/s00262-010-0855-8 10.1126/science.7716514 10.1158/1535-7163.MCT-09-0270 10.1053/gast.2003.50011 |
| ContentType | Journal Article |
| Copyright | Springer Science+Business Media, LLC 2011 COPYRIGHT 2011 Springer |
| Copyright_xml | – notice: Springer Science+Business Media, LLC 2011 – notice: COPYRIGHT 2011 Springer |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7TO 7X7 7XB 88E 8AO 8C1 8FI 8FJ 8FK 8FQ 8FV ABUWG AFKRA BENPR CCPQU DWQXO FYUFA GHDGH H94 K9. M0S M1P M3G PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS Q9U 7X8 |
| DOI | 10.1007/s10555-011-9324-x |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Oncogenes and Growth Factors Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Canadian Business & Current Affairs Database Canadian Business & Current Affairs Database (Alumni) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database CBCA Reference & Current Events ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Oncogenes and Growth Factors Abstracts ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Pharma Collection ProQuest Central China ProQuest Central CBCA Complete (Alumni Edition) ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection AIDS and Cancer Research Abstracts CBCA Complete ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Public Health ProQuest Central Basic ProQuest One Academic Eastern Edition CBCA Reference & Current Events ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | Oncogenes and Growth Factors Abstracts MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1573-7233 |
| EndPage | 385 |
| ExternalDocumentID | 2536029051 A712964796 22134655 10_1007_s10555_011_9324_x |
| Genre | Research Support, Non-U.S. Gov't Journal Article Review |
| GroupedDBID | --- -4W -5E -5G -BR -EM -Y2 -~C .86 .GJ .VR 06C 06D 0R~ 0VY 1N0 1SB 2.D 203 28- 29B 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2P1 2VQ 2~H 30V 3SX 3V. 4.4 406 408 409 40D 40E 53G 5QI 5RE 5VS 67Z 6J9 6NX 78A 7X7 88E 8AO 8C1 8FI 8FJ 8FQ 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJJC AAJKR AANXM AANZL AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYZH ABAKF ABBBX ABBXA ABDZT ABECU ABFTV ABHLI ABHQN ABJNI ABJOX ABKCH ABKTR ABMNI ABMQK ABNWP ABPLI ABQBU ABQSL ABSXP ABTEG ABTHY ABTKH ABTMW ABULA ABUWG ABWNU ABXPI ACAOD ACBXY ACDTI ACGFO ACGFS ACHSB ACHVE ACHXU ACIWK ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACPRK ACREN ACZOJ ADBBV ADHHG ADHIR ADIMF ADINQ ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADYOE ADYPR ADZKW AEBTG AEFIE AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFEXP AFKRA AFLOW AFQWF AFRAH AFWTZ AFYQB AFZKB AGAYW AGDGC AGGDS AGJBK AGMZJ AGQEE AGQMX AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHKAY AHMBA AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJRNO AJZVZ AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMTXH AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG AVWKF AXYYD AZFZN B-. BA0 BBWZM BDATZ BENPR BGNMA BPHCQ BSONS BVXVI CAG CCPQU COF CSCUP DDRTE DL5 DNIVK DPUIP DU5 DWQXO EBD EBLON EBS EIOEI EJD EMOBN EN4 EPAXT ESBYG F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 GQ8 GXS H13 HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ I09 IAO ICQ IH2 IHE IJ- IKXTQ ITC ITM IWAJR IXC IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV KOW KPH LAK LLZTM M1P M3G M4Y MA- N2Q N9A NB0 NDZJH NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM OVD P19 P2P P9S PF0 PQQKQ PROAC PSQYO PT4 PT5 Q2X QOK QOR QOS R4E R89 R9I RHV RNI RNS ROL RPX RRX RSV RZC RZE RZK S16 S1Z S26 S27 S28 S37 S3B SAP SBY SCLPG SDH SDM SHX SISQX SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZN T13 T16 TEORI TSG TSK TSV TT1 TUC U2A U9L UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WH7 WJK WK6 WK8 YLTOR Z45 Z7U Z82 Z87 Z8O Z8V Z91 ZGI ZMTXR ZOVNA ~EX AAPKM AAYXX ABBRH ABDBE ABFSG ACMFV ACSTC ADHKG AEZWR AFDZB AFHIU AFOHR AGQPQ AHPBZ AHWEU AIXLP ATHPR AYFIA CITATION PHGZM PHGZT ABRTQ CGR CUY CVF ECM EIF NPM PJZUB PPXIY AEIIB PMFND 7TO 7XB 8FK H94 K9. PKEHL PQEST PQUKI PRINS PUEGO Q9U 7X8 |
| ID | FETCH-LOGICAL-c464t-cb1b160aa60128a5378ca0335beae0e5635f68cdea59e0cda9c4ceb2b4dfccdd3 |
| IEDL.DBID | U2A |
| ISSN | 0167-7659 1573-7233 |
| IngestDate | Sun Aug 24 04:10:40 EDT 2025 Sat Aug 23 12:35:48 EDT 2025 Tue Jun 17 21:30:43 EDT 2025 Tue Jun 10 15:36:02 EDT 2025 Tue Jun 10 20:35:51 EDT 2025 Mon Jul 21 06:05:26 EDT 2025 Tue Jul 01 05:18:29 EDT 2025 Thu Apr 24 23:04:40 EDT 2025 Fri Feb 21 02:41:46 EST 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 3-4 |
| Keywords | Cytochrome Cyclooxygenase Arachidonic acid Lipoxygenase Colorectal cancer 450 |
| Language | English |
| License | http://www.springer.com/tdm |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c464t-cb1b160aa60128a5378ca0335beae0e5635f68cdea59e0cda9c4ceb2b4dfccdd3 |
| Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 ObjectType-Article-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
| PMID | 22134655 |
| PQID | 910809647 |
| PQPubID | 36268 |
| PageCount | 23 |
| ParticipantIDs | proquest_miscellaneous_911944103 proquest_journals_910809647 gale_infotracmisc_A712964796 gale_infotraccpiq_712964796 gale_infotracacademiconefile_A712964796 pubmed_primary_22134655 crossref_citationtrail_10_1007_s10555_011_9324_x crossref_primary_10_1007_s10555_011_9324_x springer_journals_10_1007_s10555_011_9324_x |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 20111200 2011-12-00 2011-Dec 20111201 |
| PublicationDateYYYYMMDD | 2011-12-01 |
| PublicationDate_xml | – month: 12 year: 2011 text: 20111200 |
| PublicationDecade | 2010 |
| PublicationPlace | Boston |
| PublicationPlace_xml | – name: Boston – name: Netherlands – name: Dordrecht |
| PublicationTitle | Cancer and metastasis reviews |
| PublicationTitleAbbrev | Cancer Metastasis Rev |
| PublicationTitleAlternate | Cancer Metastasis Rev |
| PublicationYear | 2011 |
| Publisher | Springer US Springer Springer Nature B.V |
| Publisher_xml | – name: Springer US – name: Springer – name: Springer Nature B.V |
| References | MannJRBacklundMGBuchananFGDaikokuTHollaVRRosenbergDWRepression of prostaglandin dehydrogenase by epidermal growth factor and snail increases prostaglandin E2 and promotes cancer progressionCancer Research2006661366496656168186381:CAS:528:DC%2BD28XmsVamtbg%3D JiangJ. G.FuX. N.ChenC. L.WangD. W.Expression of cytochrome P450 arachidonic acid epoxygenase 2J2 in human tumor tissues and cell lines. [Research Support, Non-U.S. Gov’t]Ai Zheng20092829396 TongWGDingXZAdrianTEThe mechanisms of lipoxygenase inhibitor-induced apoptosis in human breast cancer cellsBiochemical and Biophysical Research Communications20022964942948122001391:CAS:528:DC%2BD38XmsV2ku7c%3D KabashimaKSajiTMurataTNagamachiMMatsuokaTSegiEThe prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gutThe Journal of Clinical Investigation20021097883893119276151:CAS:528:DC%2BD38Xis1Kju70%3D HongJBoseMJuJRyuJHChenXSangSModulation of arachidonic acid metabolism by curcumin and related beta-diketone derivatives: effects on cytosolic phospholipase A(2), cyclooxygenases and 5-lipoxygenaseCarcinogenesis200425916711679150730461:CAS:528:DC%2BD2cXntFaiurk%3D WuKKLiouJYCyclooxygenase inhibitors induce colon cancer cell apoptosis Via PPARdelta -> 14-3-3epsilon pathwayMethods in Molecular Biology2009512295307193472841:CAS:528:DC%2BC3cXmt1yrtQ%3D%3D IshizukaTChengJSinghHVittoMDManthatiVLFalckJR20-Hydroxyeicosatetraenoic acid stimulates nuclear factor-kappaB activation and the production of inflammatory cytokines in human endothelial cellsJournal of Pharmacology and Experimental Therapeutics20083241103110179474961:CAS:528:DC%2BD1cXhsF2itw%3D%3D Wasilewicz, M. P., Kolodziej, B., Bojulko, T., Kaczmarczyk, M., Sulzyc-Bielicka, V., Bielicki, D., et al. (2010). Overexpression of 5-lipoxygenase in sporadic colonic adenomas and a possible new aspect of colon carcinogenesis. [Research Support, Non-U.S. Gov’t]. International Journal of Colorectal Disease, 25(9), 1079–1085, doi:10.1007/s00384–010-0980-z. GiancottiFGRuoslahtiEIntegrin signalingScience1999285543010281032104460411:CAS:528:DyaK1MXlt1Gns7o%3D ZeldinDCEpoxygenase pathways of arachidonic acid metabolism. [Review]Journal of Biological Chemistry2001276393605936062114519641:CAS:528:DC%2BD3MXnt1yku7o%3D WangDDuboisRNPeroxisome proliferator-activated receptors and progression of colorectal cancerPPAR Research2008200893107418551185 WangDWangHGuoYNingWKatkuriSWahliWCrosstalk between peroxisome proliferator-activated receptor delta and VEGF stimulates cancer progressionProceedings of the National Academy of Sciences of the United States of America2006103501906919074171486041:CAS:528:DC%2BD28XhtlersrjN PetrikMBMcEnteeMFChiuCHWhelanJAntagonism of arachidonic acid is linked to the antitumorigenic effect of dietary eicosapentaenoic acid in Apc(Min/+) miceJournal of Nutrition2000130511531158108019121:CAS:528:DC%2BD3cXivFKntLs%3D FunkCDProstaglandins and leukotrienes: advances in eicosanoid biologyScience2001294554818711875117293031:CAS:528:DC%2BD3MXovFSqurw%3D SenoHOshimaMIshikawaTOOshimaHTakakuKChibaTCyclooxygenase 2- and prostaglandin E(2) receptor EP(2)-dependent angiogenesis in Apc(Delta716) mouse intestinal polypsCancer Research2002622506511118097021:CAS:528:DC%2BD38XhtVyht7k%3D BombardierC.LaineL.ReicinA.ShapiroD.Burgos-VargasR.DavisB.Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study GroupNew England Journal of Medicine20003432115201528 Funk, C. D. (1993). Molecular biology in the eicosanoid field. [Research Support, U.S. Gov’t, P.H.S. Review]. Progress in Nucleic Acid Research & Molecular Biology, 45, 67–98. FelsenfeldDPChoquetDSheetzMPLigand binding regulates the directed movement of beta1 integrins on fibroblastsNature1996383659943844088377761:CAS:528:DyaK28Xmt1yktbg%3D FuJYMasferrerJLSeibertKRazANeedlemanPThe induction and suppression of prostaglandin H2 synthase (cyclooxygenase) in human monocytesJournal of Biological Chemistry199026528167371674021202051:CAS:528:DyaK3cXlvV2lsL0%3D FujinoHToyomuraKChenXBReganJWMurayamaTProstaglandin E regulates cellular migration via induction of vascular endothelial growth factor receptor-1 in HCA-7 human colon cancer cellsBiochemical Pharmacology2011813379387210707491:CAS:528:DC%2BC3cXhs1ajtrvL GrauRIniguezMAFresnoMInhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanismCancer Research2004641551625171152893201:CAS:528:DC%2BD2cXmtF2mtLg%3D W.H.O. (2005). Global action against cancer. (pp. 1–24). World Health Organisation and International Union Against Cancer. XiaDHollaVRWangDMenterDGDuBoisRNHEF1 is a crucial mediator of the proliferative effects of prostaglandin E(2) on colon cancer cellsCancer Research2010702824831200681651:CAS:528:DC%2BC3cXltlaisw%3D%3D Sheetz, M. P., Felsenfeld, D. P., & Galbraith, C. G. (1998). Cell migration: regulation of force on extracellular-matrix–integrin complexes. [Research Support, Non-U.S. Gov’t Research Support, U.S. Gov’t, P.H.S. Review]. Trends in Cell Biology, 8(2), 51–54. TerzuoliEDonniniSGiachettiAIniguezMAFresnoMMelilloGInhibition of hypoxia inducible factor-1alpha by dihydroxyphenylethanol, a product from olive oil, blocks microsomal prostaglandin-E synthase-1/vascular endothelial growth factor expression and reduces tumor angiogenesisClinical Cancer Research2010161642074216206827101:CAS:528:DC%2BC3cXhtVajs7rP WangDWangHBrownJDaikokuTNingWShiQCXCL1 induced by prostaglandin E2 promotes angiogenesis in colorectal cancerThe Journal of Experimental Medicine20062034941951165673911:CAS:528:DC%2BD28Xjsl2is7g%3D SolomonSDMcMurrayJJPfefferMAWittesJFowlerRFinnPCardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma preventionThe New England Journal of Medicine20053521110711080157139441:CAS:528:DC%2BD2MXit1Kqur4%3D RheeJSBlackMSchubertUFischerSMorgensternEHammesHPThe functional role of blood platelet components in angiogenesisThrombosis and Haemostasis2004922394402152698371:CAS:528:DC%2BD2cXmvVertb8%3D KuntzSWenzelUDanielHComparative analysis of the effects of flavonoids on proliferation, cytotoxicity, and apoptosis in human colon cancer cell linesEuropean Journal of Nutrition1999383133142104433351:CAS:528:DyaK1MXkvVClsL4%3D DragovichTBurrisH3rdLoehrerPVon HoffDDChowSStrattonSGemcitabine plus celecoxib in patients with advanced or metastatic pancreatic adenocarcinoma: results of a phase II trialAmerican Journal of Clinical Oncology2008312157162183916001:CAS:528:DC%2BD1cXltVGksLo%3D HernandezYSotolongoJBreglioKConduahDChenAXuRThe role of prostaglandin E2 (PGE 2) in toll-like receptor 4 (TLR4)-mediated colitis-associated neoplasiaBMC Gastroenterology2010108220637112 RaoCVRivensonASimiBReddyBSChemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compoundCancer Research199555225926678129551:CAS:528:DyaK2MXjtFyjs7Y%3D YangLHuangYPortaRYanagisawaKGonzalezASegiEHost and direct antitumor effects and profound reduction in tumor metastasis with selective EP4 receptor antagonismCancer Research2006661996659672170186241:CAS:528:DC%2BD28XhtVams73P MyungSJRerkoRMYanMPlatzerPGudaKDotsonA15-Hydroxyprostaglandin dehydrogenase is an in vivo suppressor of colon tumorigenesisProceedings of the National Academy of Sciences of the United States of America2006103321209812102168804061:CAS:528:DC%2BD28Xotlyju7Y%3D KaliberovaLNKusmartsevSAKrendelchtchikovaVStockardCRGrizzleWEBuchsbaumDJExperimental cancer therapy using restoration of NAD+-linked 15-hydroxyprostaglandin dehydrogenase expressionMolecular Cancer Therapeutics200981131303139198875441:CAS:528:DC%2BD1MXhtlyrt7%2FF YeYNLiuESShinVYWuWKChoCHThe modulating role of nuclear factor-kappaB in the action of alpha7-nicotinic acetylcholine receptor and cross-talk between 5-lipoxygenase and cyclooxygenase-2 in colon cancer growth induced by 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanoneJournal of Pharmacology and Experimental Therapeutics20043111123130151619351:CAS:528:DC%2BD2cXosVKrtro%3D AndersonKMSeedTVosMMulshineJMengJAlrefaiW5-Lipoxygenase inhibitors reduce PC-3 cell proliferation and initiate nonnecrotic cell deathProstate199837316117397921331:CAS:528:DyaK1cXntFSnu78%3D GuptaRATanJKrauseWFGeraciMWillsonTMDeySKProstacyclin mediated activation of peroxisome proliferator-activated receptor delta in colorectal cancerProceedings of the National Academy of Sciences of the United States of America2000971327513280110878691:CAS:528:DC%2BD3cXosVOjsr8%3D SubbarayanVXuXCKimJYangPHoqueASabichiALInverse relationship between 15-lipoxygenase-2 and PPAR-gamma gene expression in normal epithelia compared with tumor epitheliaNeoplasia200573280293157998281:CAS:528:DC%2BD2MXjs1Krs7c%3D KawamoriTKitamuraTWatanabeKUchiyaNMaruyamaTNarumiyaSProstaglandin E receptor subtype EP(1) deficiency inhibits colon cancer developmentCarcinogenesis2005262353357155642921:CAS:528:DC%2BD2MXmsVykuw%3D%3D ArisatoTHashiguchiTSarkerKPArimuraKAsanoMMatsuoKHighly accumulated platelet vascular endothelial growth factor in coagulant thrombotic regionJournal of Thrombosis and Haemostasis200311225892593146750941:CAS:528:DC%2BD2cXktFOlsbY%3D HonnKVCiconeBSkoffAProstacyclin: a potent antimetastatic agentScience198121245001270127270155121:CAS:528:DyaL3MXktlKjtr0%3D GustafssonAHanssonEKressnerUNordgrenSAnderssonMLonnrothCProstanoid receptor expression in colorectal cancer related to tumor stage, differentiation and progressionActa Oncologica200746811071112179434721:CAS:528:DC%2BD2sXht1GrsrnK Hanahan, D., & Weinberg, R. A. (2011). Hallmarks of cancer: the next generation. [Research Support, N.I.H., Extramural Review]. Cell, 144(5), 646–674, doi:10.1016/j.cell.2011.02.013. Jiang, J. G., Chen, R. J., Xiao, B., Yang, S., Wang, J. N., Wang, Y., et al. (2007). Regulation of endothelial nitric-oxide synthase activity thro MB Petrik (9324_CR200) 2000; 130 L Yang (9324_CR151) 2006; 66 RJ Bing (9324_CR68) 2001; 7 BB Davis (9324_CR181) 2011; 410 I Yokoyama (9324_CR158) 1995; 195 9324_CR163 KN Theken (9324_CR179) 2010; 39 T Lawrence (9324_CR175) 2002; 2 P Carmeliet (9324_CR132) 2000; 407 9324_CR160 X Qian (9324_CR170) 2010; 286 N Arber (9324_CR22) 2005; 166 KM Sheehan (9324_CR33) 2004; 16 A Catalano (9324_CR29) 2005; 20 G Hawcroft (9324_CR25) 2010; 12 BM Forman (9324_CR44) 1997; 94 BB Aggarwal (9324_CR218) 2004; 24 B Zhang (9324_CR177) 2011; 185 GW Daneker (9324_CR157) 1996; 14 D Panigrahy (9324_CR18) 2010; 29 9324_CR148 A Gustafsson (9324_CR67) 2007; 46 L Michalik (9324_CR114) 2004; 4 A Jakobsen (9324_CR9) 2008; 23 T Yoshida (9324_CR97) 1998; 28 X Chen (9324_CR86) 2004; 10 VW Yang (9324_CR16) 1998; 58 P Needleman (9324_CR38) 1976; 261 D Wang (9324_CR79) 2008; 2008 C Boccaccio (9324_CR190) 2005; 434 S Yaqub (9324_CR166) 2008; 57 I Avis (9324_CR197) 2005; 65 I Shureiqi (9324_CR26) 2001; 61 CE Eberhart (9324_CR77) 1994; 107 9324_CR24 AL Gonzalez (9324_CR82) 2004; 35 9324_CR20 9324_CR21 H Gao (9324_CR37) 1997; 273 FG Buchanan (9324_CR153) 2006; 103 H Sakai (9324_CR76) 2006; 580 H Amano (9324_CR137) 2003; 197 RE Carroll (9324_CR212) 2011; 4 LN Kaliberova (9324_CR107) 2009; 8 X Norel (9324_CR111) 2004; 103 I Loffler (9324_CR102) 2008; 8 I Shureiqi (9324_CR83) 1999; 20 O Radmark (9324_CR182) 2010; 268 RL Bick (9324_CR187) 2006; 4 9324_CR11 D Qualtrough (9324_CR159) 2007; 121 NS Cutler (9324_CR130) 2003; 63 CD Funk (9324_CR40) 2001; 294 DC Zeldin (9324_CR35) 2001; 276 C Hoffmann (9324_CR42) 2000; 7 9324_CR17 M Moriai (9324_CR119) 2009; 34 MJ Mangino (9324_CR176) 2006; 79 MM Bertagnolli (9324_CR164) 2006; 355 R Pai (9324_CR100) 2002; 8 LG Melstrom (9324_CR93) 2008; 14 F Baratelli (9324_CR165) 2005; 175 S Gupta (9324_CR88) 2001; 91 SJ Myung (9324_CR66) 2006; 103 S Ostrand-Rosenberg (9324_CR172) 2010; 59 E Ricciotti (9324_CR49) 2011; 31 A Pozzi (9324_CR103) 2004; 279 WL Smith (9324_CR5) 1989; 259 AF Sheibanie (9324_CR168) 2007; 178 9324_CR4 R Grau (9324_CR140) 2004; 64 T Kawamori (9324_CR65) 2005; 26 T Ishizuka (9324_CR178) 2008; 324 RY Su (9324_CR122) 2008; 7 MB Hansen-Petrik (9324_CR56) 2002; 62 S Norwood (9324_CR180) 2010; 2 A Leslie (9324_CR32) 2002; 89 M Sonoshita (9324_CR136) 2001; 7 9324_CR30 9324_CR108 P Pradono (9324_CR139) 2002; 62 RC Mund (9324_CR204) 2007; 76 L Wang (9324_CR123) 2008; 30 9324_CR36 FG Buchanan (9324_CR152) 2003; 278 A Ihara (9324_CR112) 2007; 103 NB Janakiram (9324_CR174) 2009; 9 J Frigola (9324_CR69) 2005; 24 P Galfi (9324_CR195) 2005; 29 DP Felsenfeld (9324_CR147) 1996; 383 MD Castellone (9324_CR101) 2005; 310 X Zuo (9324_CR80) 2009; 101 X Leval de (9324_CR34) 2006; 318 P Patrignani (9324_CR41) 1994; 271 9324_CR62 GA Doherty (9324_CR23) 2009; 13 9324_CR60 T Shimada (9324_CR120) 2002; 50 D Wang (9324_CR48) 2010; 10 A Greenhough (9324_CR127) 2010; 29 9324_CR142 S Lev-Ari (9324_CR211) 2005; 11 D Xia (9324_CR106) 2010; 70 R Fukuda (9324_CR134) 2003; 63 H Fujino (9324_CR150) 2011; 81 AJ Dannenberg (9324_CR6) 2003; 4 WG Tong (9324_CR217) 2002; 296 AJ Smith (9324_CR28) 1994; 54 GG Chen (9324_CR116) 2002; 70 9324_CR1 D Wang (9324_CR74) 2008; 267 J Vanamala (9324_CR202) 2008; 29 J Ju (9324_CR219) 2003; 46 9324_CR51 9324_CR128 9324_CR52 M Mutoh (9324_CR63) 2002; 62 9324_CR50 WG Jiang (9324_CR89) 2003; 69 J Hong (9324_CR209) 2004; 25 B Vogelstein (9324_CR31) 1988; 319 R Hennig (9324_CR194) 2004; 210 H Sheng (9324_CR126) 1998; 58 YN Ye (9324_CR113) 2004; 311 MJ Bissell (9324_CR143) 1999; 59 JS Rhee (9324_CR186) 2004; 92 Y Yudina (9324_CR173) 2008; 79 V Subbarayan (9324_CR84) 2005; 7 KV Honn (9324_CR188) 1983; 12 R Bartoli (9324_CR205) 2000; 46 DG Tang (9324_CR85) 2007; 82 YN Ye (9324_CR193) 2005; 26 SD Solomon (9324_CR15) 2005; 352 KV Honn (9324_CR155) 1981; 212 SR Zamuner (9324_CR73) 2005; 167 CN Chen (9324_CR131) 2001; 233 SW Shin (9324_CR121) 2009; 15 S Kuntz (9324_CR215) 1999; 38 V Leone (9324_CR124) 2007; 293 AR Brash (9324_CR110) 1999; 274 N Yoshida (9324_CR156) 1999; 117 D Wang (9324_CR81) 2006; 103 G Cassano (9324_CR109) 2000; 7 JM Park (9324_CR72) 2007; 67 R Pai (9324_CR154) 2003; 17 EC Cheon (9324_CR171) 2011; 71 O Galamb (9324_CR71) 2009; 31 T Dragovich (9324_CR8) 2008; 31 X Leval de (9324_CR192) 2003; 68 Q Wang (9324_CR167) 2009; 45 E Hazai (9324_CR213) 2006; 14 O Schroder (9324_CR183) 2006; 47 J Ju (9324_CR207) 2009; 2 M Yoshinaga (9324_CR115) 2004; 73 KK Wu (9324_CR129) 2009; 512 D Wang (9324_CR47) 2004; 6 W Bednar (9324_CR214) 2007; 45 D Wang (9324_CR138) 2006; 203 G Bergers (9324_CR133) 2003; 3 TO Daniel (9324_CR185) 1999; 59 LA Feagins (9324_CR161) 2009; 6 G Calviello (9324_CR201) 2004; 25 9324_CR95 9324_CR96 9324_CR94 9324_CR91 9324_CR92 X Gao (9324_CR87) 1995; 46 Y Hernandez (9324_CR58) 2010; 10 DM Klurfeld (9324_CR3) 1997; 66 MG Sciulli (9324_CR78) 2005; 72 MG Backlund (9324_CR55) 2005; 280 DP Cherukuri (9324_CR104) 2007; 313 K Watanabe (9324_CR64) 1999; 59 A Koeberle (9324_CR208) 2009; 8 RC Harris (9324_CR43) 1994; 94 SA Kliewer (9324_CR45) 1997; 94 T Kawamori (9324_CR57) 2003; 24 FG Giancotti (9324_CR144) 1999; 285 M Cuendet (9324_CR2) 2000; 17 HM Pinedo (9324_CR189) 1998; 352 KM Anderson (9324_CR196) 1998; 37 D Wang (9324_CR99) 2005; 65 EA Clark (9324_CR145) 1995; 268 RA Gupta (9324_CR46) 2000; 97 ES Antonarakis (9324_CR7) 2009; 27 M Bose (9324_CR203) 2007; 55 M Koyama (9324_CR117) 2010; 16 RS Bresalier (9324_CR12) 2005; 352 SW Park (9324_CR105) 2011; 336 F Cianchi (9324_CR198) 2006; 5 GP Pidgeon (9324_CR216) 2002; 62 K Kabashima (9324_CR70) 2002; 109 M Nakanishi (9324_CR59) 2008; 68 R Chinery (9324_CR98) 1999; 59 A Howe (9324_CR146) 1998; 10 JY Fu (9324_CR39) 1990; 265 A Helin-Salmivaara (9324_CR13) 2006; 27 E Terzuoli (9324_CR206) 2010; 16 YN Ye (9324_CR141) 2005; 519 VA Papadimitrakopoulou (9324_CR10) 2008; 14 PM Kearney (9324_CR14) 2006; 332 JF Ohd (9324_CR90) 2003; 124 JR Mann (9324_CR75) 2006; 66 S Tanaka (9324_CR169) 2006; 55 D Hanahan (9324_CR19) 2000; 100 N Elander (9324_CR61) 2008; 372 H Seno (9324_CR135) 2002; 62 M Mal (9324_CR54) 2011; 25 SM Powell (9324_CR27) 1992; 359 FR Rickles (9324_CR191) 2006; 35 FV Din (9324_CR162) 2010; 59 MS Lin (9324_CR118) 2007; 8 F Cianchi (9324_CR149) 2001; 121 CP Caygill (9324_CR199) 1996; 74 B Rigas (9324_CR53) 1993; 122 CV Rao (9324_CR210) 1995; 55 T Arisato (9324_CR184) 2003; 1 J Kaur (9324_CR125) 2010; 31 |
| References_xml | – reference: FukudaRKellyBSemenzaGLVascular endothelial growth factor gene expression in colon cancer cells exposed to prostaglandin E2 is mediated by hypoxia-inducible factor 1Cancer Research200363923302334127278581:CAS:528:DC%2BD3sXjtlGmtLc%3D – reference: KawamoriTUchiyaNSugimuraTWakabayashiKEnhancement of colon carcinogenesis by prostaglandin E2 administrationCarcinogenesis2003245985990127710441:CAS:528:DC%2BD3sXkt1WrsLY%3D – reference: LeoneVdi PalmaARicchiPAcquavivaFGiannouliMDi PriscoAMPGE2 inhibits apoptosis in human adenocarcinoma Caco-2 cell line through Ras-PI3K association and cAMP-dependent kinase A activationAmerican Journal of Physiology—Gastrointestinal and Liver Physiology20072934G673G681176409741:CAS:528:DC%2BD2sXht1WrsbjN – reference: de LevalXDassesseTDogneJMWaltregnyDBellahceneABenoitVEvaluation of original dual thromboxane A2 modulators as antiangiogenic agentsJournal of Pharmacology and Experimental Therapeutics200631831057106716720756 – reference: MalMKohPKCheahPYChanECUltra-pressure liquid chromatography/tandem mass spectrometry targeted profiling of arachidonic acid and eicosanoids in human colorectal cancerRapid Communications in Mass Spectrometry2011256755764213376371:CAS:528:DC%2BC3MXit1Ghtro%3D – reference: PapadimitrakopoulouVAWilliamWNJrDannenbergAJLippmanSMLeeJJOndreyFGPilot randomized phase II study of celecoxib in oral premalignant lesionsClinical Cancer Research200814720952101183819501:CAS:528:DC%2BD1cXkt1aku7o%3D – reference: GalfiPNeogradyZAmbergerAMargreiterRCsordasASensitization of colon cancer cell lines to butyrate-mediated proliferation inhibition by combined application of indomethacin and nordihydroguaiaretic acidCancer Detection and Prevention2005293276285159365961:CAS:528:DC%2BD2MXms1egsbs%3D – reference: CianchiFCortesiniCMagnelliLFantiEPapucciLSchiavoneNInhibition of 5-lipoxygenase by MK886 augments the antitumor activity of celecoxib in human colon cancer cellsMolecular Cancer Therapeutics200651127162726171219181:CAS:528:DC%2BD28Xht1els7nL – reference: FuJYMasferrerJLSeibertKRazANeedlemanPThe induction and suppression of prostaglandin H2 synthase (cyclooxygenase) in human monocytesJournal of Biological Chemistry199026528167371674021202051:CAS:528:DyaK3cXlvV2lsL0%3D – reference: FrigolaJMunozMClarkSJMorenoVCapellaGPeinadoMAHypermethylation of the prostacyclin synthase (PTGIS) promoter is a frequent event in colorectal cancer and associated with aneuploidyOncogene2005244973207326160071281:CAS:528:DC%2BD2MXhtF2ns7%2FK – reference: ChenCNSungCTLinMTLeePHChangKJClinicopathologic association of cyclooxygenase 1 and cyclooxygenase 2 expression in gastric adenocarcinomaAnnals of Surgery20012332183188111761231:STN:280:DC%2BD3M7ls1SntQ%3D%3D – reference: SubbarayanVXuXCKimJYangPHoqueASabichiALInverse relationship between 15-lipoxygenase-2 and PPAR-gamma gene expression in normal epithelia compared with tumor epitheliaNeoplasia200573280293157998281:CAS:528:DC%2BD2MXjs1Krs7c%3D – reference: PinedoHMVerheulHMD’AmatoRJFolkmanJInvolvement of platelets in tumour angiogenesis?Lancet199835291421775177798483701:STN:280:DyaK1M%2FmtlWitA%3D%3D – reference: Lev-AriSStrierLKazanovDMadar-ShapiroLDvory-SobolHPinchukICelecoxib and curcumin synergistically inhibit the growth of colorectal cancer cellsClinical Cancer Research2005111867386744161664551:CAS:528:DC%2BD2MXhtVShsb3J – reference: Hansen-PetrikMBMcEnteeMFJullBShiHZemelMBWhelanJProstaglandin E(2) protects intestinal tumors from nonsteroidal anti-inflammatory drug-induced regression in Apc(Min/+) miceCancer Research2002622403408118096881:CAS:528:DC%2BD38XhtVyhtr0%3D – reference: HernandezYSotolongoJBreglioKConduahDChenAXuRThe role of prostaglandin E2 (PGE 2) in toll-like receptor 4 (TLR4)-mediated colitis-associated neoplasiaBMC Gastroenterology2010108220637112 – reference: TerzuoliEDonniniSGiachettiAIniguezMAFresnoMMelilloGInhibition of hypoxia inducible factor-1alpha by dihydroxyphenylethanol, a product from olive oil, blocks microsomal prostaglandin-E synthase-1/vascular endothelial growth factor expression and reduces tumor angiogenesisClinical Cancer Research2010161642074216206827101:CAS:528:DC%2BC3cXhtVajs7rP – reference: W.H.O. (2008). GLOBOCAN 2008 fast stats. (pp. 1–8). International Agency for Research on Cancer. – reference: WangDDuBoisRNPro-inflammatory prostaglandins and progression of colorectal cancerCancer Letters20082672197203184065161:CAS:528:DC%2BD1cXovF2hsLg%3D – reference: ChenXWangSWuNSoodSWangPJinZOverexpression of 5-lipoxygenase in rat and human esophageal adenocarcinoma and inhibitory effects of zileuton and celecoxib on carcinogenesisClinical Cancer Research2004101967036709154754611:CAS:528:DC%2BD2cXot1Ohsr0%3D – reference: Pidgeon, G. P., Lysaght, J., Krishnamoorthy, S., Reynolds, J. V., O’Byrne, K., Nie, D., et al. (2007). Lipoxygenase metabolism: roles in tumor progression and survival. [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t Research Support, U.S. Gov’t, Non-P.H.S. Review]. Cancer and Metastasis Reviews, 26(3–4), 503–524, doi:10.1007/s10555-007-9098-3. – reference: Sheetz, M. P., Felsenfeld, D. P., & Galbraith, C. G. (1998). Cell migration: regulation of force on extracellular-matrix–integrin complexes. [Research Support, Non-U.S. Gov’t Research Support, U.S. Gov’t, P.H.S. Review]. Trends in Cell Biology, 8(2), 51–54. – reference: CassanoGGasparreGSuscaFLippeCGuantiGLack of effect by prostaglandin F2alpha on the proliferation of the HCT-8 and HT-29 human adenocarcinoma cell linesOncology Reports200071183186106016151:CAS:528:DC%2BD3cXjslKgsg%3D%3D – reference: QualtroughDKaidiAChellSJabbourHNWilliamsACParaskevaCProstaglandin F(2alpha) stimulates motility and invasion in colorectal tumor cellsInternational Journal of Cancer200712147347401:CAS:528:DC%2BD2sXotleqtbg%3D – reference: YudinaYParhamifarLBengtssonAMJuhasMSjolanderARegulation of the eicosanoid pathway by tumour necrosis factor alpha and leukotriene D4 in intestinal epithelial cellsProstaglandins, Leukotrienes, and Essential Fatty Acids2008796223231190421131:CAS:528:DC%2BD1cXhsVKrtLfK – reference: SheehanKMO’ConnellFO’GradyAConroyRMLeaderMBByrneMFThe relationship between cyclooxygenase-2 expression and characteristics of malignant transformation in human colorectal adenomasEuropean Journal of Gastroenterology and Hepatology2004166619625151671661:CAS:528:DC%2BD2cXksVKgsLs%3D – reference: HonnKVCiconeBSkoffAProstacyclin: a potent antimetastatic agentScience198121245001270127270155121:CAS:528:DyaL3MXktlKjtr0%3D – reference: HazaiEBikadiZZsilaFLockwoodSFMolecular modeling of the non-covalent binding of the dietary tomato carotenoids lycopene and lycophyll, and selected oxidative metabolites with 5-lipoxygenaseBioorganic & Medicinal Chemistry20061420685968671:CAS:528:DC%2BD28XptFSks7k%3D – reference: YeYNWuWKShinVYChoCHA mechanistic study of colon cancer growth promoted by cigarette smoke extractEuropean Journal of Pharmacology20055191–25257161251681:CAS:528:DC%2BD2MXpslymsL8%3D – reference: Helin-SalmivaaraAVirtanenAVesalainenRGronroosJMKlaukkaTIdanpaan-HeikkilaJENSAID use and the risk of hospitalization for first myocardial infarction in the general population: a nationwide case–control study from FinlandEuropean Heart Journal200627141657166316731535 – reference: CarmelietPJainRKAngiogenesis in cancer and other diseasesNature20004076801249257110010681:CAS:528:DC%2BD3cXmvVSls74%3D – reference: HawcroftGLoadmanPMBelluzziAHullMAEffect of eicosapentaenoic acid on E-type prostaglandin synthesis and EP4 receptor signaling in human colorectal cancer cellsNeoplasia2010128618627206897561:CAS:528:DC%2BC3cXpvVClsr4%3D – reference: BuchananFGWangDBargiacchiFDuBoisRNProstaglandin E2 regulates cell migration via the intracellular activation of the epidermal growth factor receptorJournal of Biological Chemistry2003278373545135457128241871:CAS:528:DC%2BD3sXntVajsrw%3D – reference: ChineryRCoffeyRJGraves-DealRKirklandSCSanchezSCZackertWEProstaglandin J2 and 15-deoxy-delta12,14-prostaglandin J2 induce proliferation of cyclooxygenase-depleted colorectal cancer cellsCancer Research1999591127392746103640001:CAS:528:DyaK1MXjs1ymt7s%3D – reference: JiangWGDouglas-JonesAManselRELevels of expression of lipoxygenases and cyclooxygenase-2 in human breast cancerProstaglandins, Leukotrienes, and Essential Fatty Acids2003694275281129071381:CAS:528:DC%2BD3sXlvFOku7Y%3D – reference: HonnKVSloaneBFProstacyclin, thromboxanes, and hematogenous metastasisAdvances in Prostaglandin, Thromboxane, and Leukotriene Research19831231331862216091:CAS:528:DyaL3sXhvFGkt7w%3D – reference: JakobsenAMortensenJPBisgaardCLindebjergJRafaelsenSRBendtsenVOA COX-2 inhibitor combined with chemoradiation of locally advanced rectal cancer: a phase II trialInternational Journal of Colorectal Disease200823325125518064474 – reference: JanakiramNBRaoCVRole of lipoxins and resolvins as anti-inflammatory and proresolving mediators in colon cancerCurrent Molecular Medicine200995565579196018071:CAS:528:DC%2BD1MXntVCjurs%3D – reference: WangDWangHShiQKatkuriSWalhiWDesvergneBProstaglandin E(2) promotes colorectal adenoma growth via transactivation of the nuclear peroxisome proliferator-activated receptor deltaCancer Cell200463285295153805191:CAS:528:DC%2BD2cXot1KisL4%3D – reference: LawrenceTWilloughbyDAGilroyDWAnti-inflammatory lipid mediators and insights into the resolution of inflammationNature Reviews Immunology2002210787795123602161:CAS:528:DC%2BD38XnsVGqtr8%3D – reference: CastelloneMDTeramotoHWilliamsBODrueyKMGutkindJSProstaglandin E2 promotes colon cancer cell growth through a Gs-axin-beta-catenin signaling axisScience2005310575315041510162937241:CAS:528:DC%2BD2MXht1GqsrvF – reference: WangDDuboisRNEicosanoids and cancerNature Reviews. Cancer2010103181193201683191:CAS:528:DC%2BC3cXitFemsbs%3D – reference: BissellMJWeaverVMLelievreSAWangFPetersenOWSchmeichelKLTissue structure, nuclear organization, and gene expression in normal and malignant breastCancer Research1999597 Suppl1757s1763s1:CAS:528:DyaK1MXisVWrs7Y%3Ddiscussion 1763s–1764s – reference: BartoliRFernandez-BanaresFNavarroECastellaEManeJAlvarezMEffect of olive oil on early and late events of colon carcinogenesis in rats: modulation of arachidonic acid metabolism and local prostaglandin E(2) synthesisGut2000462191199106443121:CAS:528:DC%2BD3cXhtFyrtb4%3D – reference: PetrikMBMcEnteeMFChiuCHWhelanJAntagonism of arachidonic acid is linked to the antitumorigenic effect of dietary eicosapentaenoic acid in Apc(Min/+) miceJournal of Nutrition2000130511531158108019121:CAS:528:DC%2BD3cXivFKntLs%3D – reference: SakaiHSuzukiTTakahashiYUkaiMTauchiKFujiiTUpregulation of thromboxane synthase in human colorectal carcinoma and the cancer cell proliferation by thromboxane A2FEBS Letters20065801433683374167094111:CAS:528:DC%2BD28Xltlens70%3D – reference: HennigRDingXZTongWGWittRCJovanovicBDAdrianTEEffect of LY293111 in combination with gemcitabine in colonic cancerCancer Letters200421014146151721191:CAS:528:DC%2BD2cXksVCisLk%3D – reference: BergersGBenjaminLETumorigenesis and the angiogenic switchNature Reviews. Cancer200336401410127781301:CAS:528:DC%2BD3sXktFOnsb8%3D – reference: CutlerNSGraves-DealRLaFleurBJGaoZBomanBMWhiteheadRHStromal production of prostacyclin confers an antiapoptotic effect to colonic epithelial cellsCancer Research200363817481751127025551:CAS:528:DC%2BD3sXivFynsr8%3D – reference: YoshidaTOhkiSKanazawaMMizunumaHKikuchiYSatohHInhibitory effects of prostaglandin D2 against the proliferation of human colon cancer cell lines and hepatic metastasis from colorectal cancerSurgery Today199828774074596972691:CAS:528:DyaK1cXlt1ejtro%3D – reference: YoshidaNYoshikawaTNakagawaSSakamotoKNakamuraYNaitoYEffect of shear stress and a stable prostaglandin I2 analogue on adhesive interactions of colon cancer cells and endothelial cellsClinical and Experimental Immunology19991173430434104690431:CAS:528:DyaK1MXmtV2ku7o%3D – reference: BresalierRSSandlerRSQuanHBologneseJAOxeniusBHorganKCardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trialThe New England Journal of Medicine20053521110921102157139431:CAS:528:DC%2BD2MXit1Kqu7o%3D – reference: ZhangBJiaHLiuJYangZJiangTTangKDepletion of regulatory T cells facilitates growth of established tumors: a mechanism involving the regulation of myeloid-derived suppressor cells by lipoxin A4Journal of Immunology20111851271997206 – reference: FunkCDProstaglandins and leukotrienes: advances in eicosanoid biologyScience2001294554818711875117293031:CAS:528:DC%2BD3MXovFSqurw%3D – reference: YeYNLiuESShinVYWuWKChoCHThe modulating role of nuclear factor-kappaB in the action of alpha7-nicotinic acetylcholine receptor and cross-talk between 5-lipoxygenase and cyclooxygenase-2 in colon cancer growth induced by 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanoneJournal of Pharmacology and Experimental Therapeutics20043111123130151619351:CAS:528:DC%2BD2cXosVKrtro%3D – reference: Wang, D., & Dubois, R. N. The role of COX-2 in intestinal inflammation and colorectal cancer. Oncogene, 29(6), 781–788 doi: 10.1038/onc.2009.421. – reference: CalvielloGDi NicuoloFGragnoliSPiccioniESeriniSMaggianoNn−3 PUFAs reduce VEGF expression in human colon cancer cells modulating the COX-2/PGE2 induced ERK-1 and -2 and HIF-1alpha induction pathwayCarcinogenesis2004251223032310153586331:CAS:528:DC%2BD2cXhtVCrsrrL – reference: BombardierC.LaineL.ReicinA.ShapiroD.Burgos-VargasR.DavisB.Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study GroupNew England Journal of Medicine20003432115201528 – reference: TangDGBhatiaBTangSSchneider-BroussardR15-Lipoxygenase 2 (15-LOX2) is a functional tumor suppressor that regulates human prostate epithelial cell differentiation, senescence, and growth (size)Prostaglandins & Other Lipid Mediators2007821–41351461:CAS:528:DC%2BD28Xht12ktL%2FL – reference: VanamalaJGlagolenkoAYangPCarrollRJMurphyMENewmanRADietary fish oil and pectin enhance colonocyte apoptosis in part through suppression of PPARdelta/PGE2 and elevation of PGE3Carcinogenesis2008294790796180244781:CAS:528:DC%2BD1cXktlOhur4%3D – reference: Jiang, J. G., Chen, C. L., Card, J. W., Yang, S., Chen, J. X., Fu, X. N., et al. (2005). Cytochrome P450 2J2 promotes the neoplastic phenotype of carcinoma cells and is up-regulated in human tumors. [Research Support, Non-U.S. Gov’t]. Cancer Research, 65(11), 4707–4715, doi:10.1158/0008-5472.CAN-04-4173. – reference: BacklundMGMannJRHollaVRBuchananFGTaiHHMusiekES15-Hydroxyprostaglandin dehydrogenase is down-regulated in colorectal cancerJournal of Biological Chemistry2005280532173223155426091:CAS:528:DC%2BD2MXovVCrug%3D%3D – reference: LeslieACareyFAPrattNRSteeleRJThe colorectal adenoma–carcinoma sequenceBritish Journal of Surgery2002897845860120817331:STN:280:DC%2BD38zjvFCmtg%3D%3D – reference: Serhan, C. N. (2009). Systems approach to inflammation resolution: identification of novel anti-inflammatory and pro-resolving mediators. [Research Support, N.I.H., Extramural Review]. Journal of Thrombosis and Haemostasis, 7(Suppl 1), 44–48, doi:10.1111/j.1538–7836.2009.03396.x. – reference: IshizukaTChengJSinghHVittoMDManthatiVLFalckJR20-Hydroxyeicosatetraenoic acid stimulates nuclear factor-kappaB activation and the production of inflammatory cytokines in human endothelial cellsJournal of Pharmacology and Experimental Therapeutics20083241103110179474961:CAS:528:DC%2BD1cXhsF2itw%3D%3D – reference: ShinSWSeoCYHanHHanJYJeongJSKwakJY15d-PGJ2 induces apoptosis by reactive oxygen species-mediated inactivation of Akt in leukemia and colorectal cancer cells and shows in vivo antitumor activityClinical Cancer Research2009151754145425196901981:CAS:528:DC%2BD1MXhtVOntrjL – reference: WangLChenWXieXHeYBaiXCelecoxib inhibits tumor growth and angiogenesis in an orthotopic implantation tumor model of human colon cancerExperimental Oncology2008301425118438340 – reference: DanielTOLiuHMorrowJDCrewsBCMarnettLJThromboxane A2 is a mediator of cyclooxygenase-2-dependent endothelial migration and angiogenesisCancer Research1999591845744577104935101:CAS:528:DyaK1MXmtVKksbk%3D – reference: BoccaccioCSabatinoGMedicoEGirolamiFFollenziAReatoGThe MET oncogene drives a genetic programme linking cancer to haemostasisNature20054347031396400157726651:CAS:528:DC%2BD2MXit1yru78%3D – reference: NakanishiMMontroseDCClarkPNambiarPRBelinskyGSClaffeyKPGenetic deletion of mPGES-1 suppresses intestinal tumorigenesisCancer Research200868932513259184511511:CAS:528:DC%2BD1cXltlSmu7c%3D – reference: BoseMHaoXJuJHusainAParkSLambertJDInhibition of tumorigenesis in ApcMin/+ mice by a combination of (−)-epigallocatechin-3-gallate and fish oilJournal of Agricultural and Food Chemistry2007551976957700176964811:CAS:528:DC%2BD2sXptFClsL0%3D – reference: CheonECKhazaieKKhanMWStrouchMJKrantzSBPhillipsJMast cell 5-lipoxygenase activity promotes intestinal polyposis in APCDelta468 miceCancer Research201171516271636212168931:CAS:528:DC%2BC3MXisFCnsro%3D – reference: HoffmannCCOX-2 in brain and spinal cord implications for therapeutic useCurrent Medicinal Chemistry200071111131120110329611:CAS:528:DC%2BD3cXotFWrsr0%3D – reference: WuS.MoomawC. R.TomerK. B.FalckJ. R.ZeldinD. C.Molecular cloning and expression of CYP2J2, a human cytochrome P450 arachidonic acid epoxygenase highly expressed in heart. [Research Support, U.S. Gov’t, P.H.S.]Journal of Biological Chemistry1996271734603468 – reference: ShengHShaoJMorrowJDBeauchampRDDuBoisRNModulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cellsCancer Research199858236236694434181:CAS:528:DyaK1cXnt1altQ%3D%3D – reference: PowellSMZilzNBeazer-BarclayYBryanTMHamiltonSRThibodeauSNAPC mutations occur early during colorectal tumorigenesisNature1992359639223523715282641:CAS:528:DyaK38XlvV2htbY%3D – reference: WangQTakeiYKobayashiOOsadaTWatanabeSCyclooxygenase 2 modulates killing of cytotoxic T lymphocytes by colon cancer cellsJournal of Clinical Biochemistry & Nutrition20094521631701:CAS:528:DC%2BD1MXhtlWrsbvK – reference: Sasaki, Y., Kamei, D., Ishikawa, Y., Ishii, T., Uematsu, S., Akira, S., et al. (2011). Microsomal prostaglandin E synthase-1 is involved in multiple steps of colon carcinogenesis. Oncogene. doi:10.1038/onc.2011.472. – reference: Spector, A. A., Fang, X., Snyder, G. D., & Weintraub, N. L. (2004). Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function. [Research Support, Non-U.S. Gov’t Research Support, U.S. Gov’t, P.H.S. Review]. Progress in Lipid Research, 43(1), 55–90. – reference: QianXZhangJLiuJTumor-secreted PGE2 inhibits CCL5 production in activated macrophages through cAMP/PKA signaling pathwayJournal of Biological Chemistry201028632111212021097507 – reference: YokoyamaIHayashiSKobayashiTNegitaMYasutomiMUchidaKPrevention of experimental hepatic metastasis with thromboxane synthase inhibitorResearch in Experimental Medicine (Berlin)199519542092151:CAS:528:DyaK2MXptFOgtbw%3D – reference: PaiRSoreghanBSzaboILPavelkaMBaatarDTarnawskiASProstaglandin E2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophyNature Medicine200283289293118755011:CAS:528:DC%2BD38Xit1CitLk%3D – reference: CianchiFCortesiniCBechiPFantappieOMesseriniLVannacciAUp-regulation of cyclooxygenase 2 gene expression correlates with tumor angiogenesis in human colorectal cancerGastroenterology2001121613391347117291131:CAS:528:DC%2BD38Xhs12htw%3D%3D – reference: DinFVTheodoratouEFarringtonSMTenesaABarnetsonRACetnarskyjREffect of aspirin and NSAIDs on risk and survival from colorectal cancerGut2010591216701679208442931:CAS:528:DC%2BC3MXpvFei – reference: KaliberovaLNKusmartsevSAKrendelchtchikovaVStockardCRGrizzleWEBuchsbaumDJExperimental cancer therapy using restoration of NAD+-linked 15-hydroxyprostaglandin dehydrogenase expressionMolecular Cancer Therapeutics200981131303139198875441:CAS:528:DC%2BD1MXhtlyrt7%2FF – reference: ElanderNUngerbackJOlssonHUematsuSAkiraSSoderkvistPGenetic deletion of mPGES-1 accelerates intestinal tumorigenesis in APC(Min/+) miceBiochemical and Biophysical Research Communications20083721249253184858891:CAS:528:DC%2BD1cXmvFekuro%3D – reference: MannJRBacklundMGBuchananFGDaikokuTHollaVRRosenbergDWRepression of prostaglandin dehydrogenase by epidermal growth factor and snail increases prostaglandin E2 and promotes cancer progressionCancer Research2006661366496656168186381:CAS:528:DC%2BD28XmsVamtbg%3D – reference: SmithAJSternHSPennerMHayKMitriABapatBVSomatic APC and K-ras codon 12 mutations in aberrant crypt foci from human colonsCancer Research199454215527553079231901:CAS:528:DyaK2cXmvFyitr8%3D – reference: KaurJSanyalSNPI3-kinase/Wnt association mediates COX-2/PGE(2) pathway to inhibit apoptosis in early stages of colon carcinogenesis: chemoprevention by diclofenacTumour Biology2010316623631206174081:CAS:528:DC%2BC3cXht1OmtrrJ – reference: ClarkEABruggeJSIntegrins and signal transduction pathways: the road takenScience1995268520823323977165141:CAS:528:DyaK2MXltVCitLk%3D – reference: SuRYChiKHHuangDYTaiMHLinWW15-deoxy-Delta12,14-prostaglandin J2 up-regulates death receptor 5 gene expression in HCT116 cells: involvement of reactive oxygen species and C/EBP homologous transcription factor gene transcriptionMolecular Cancer Therapeutics200871034293440188521461:CAS:528:DC%2BD1cXht1ensbzE – reference: SolomonSDMcMurrayJJPfefferMAWittesJFowlerRFinnPCardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma preventionThe New England Journal of Medicine20053521110711080157139441:CAS:528:DC%2BD2MXit1Kqur4%3D – reference: WangDDuboisRNPeroxisome proliferator-activated receptors and progression of colorectal cancerPPAR Research2008200893107418551185 – reference: ArberNLevinBChemoprevention of colorectal cancer: ready for routine use?Recent Results in Cancer Research2005166213230156481921:CAS:528:DC%2BD2MXos1WisQ%3D%3D – reference: Ferlay, J., Shin, H. R., Bray, F., Forman, D., Mathers, C., & Parkin, D. M. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International Journal of Cancer, 127(12), 2893–2917, doi:10.1002/ijc.25516. – reference: FormanBMChenJEvansRMHypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and deltaProceedings of the National Academy of Sciences of the United States of America19979494312431791139861:CAS:528:DyaK2sXjtVyhsbs%3D – reference: MoriaiMTsujiNKobayashiDKuribayashiKWatanabeNDown-regulation of hTERT expression plays an important role in 15-deoxy-Delta12,14-prostaglandin J2-induced apoptosis in cancer cellsInternational Journal of Oncology200934513631372193603481:CAS:528:DC%2BD1MXlsVejurg%3D – reference: HongJBoseMJuJRyuJHChenXSangSModulation of arachidonic acid metabolism by curcumin and related beta-diketone derivatives: effects on cytosolic phospholipase A(2), cyclooxygenases and 5-lipoxygenaseCarcinogenesis200425916711679150730461:CAS:528:DC%2BD2cXntFaiurk%3D – reference: Funk, C. D. (1993). Molecular biology in the eicosanoid field. [Research Support, U.S. Gov’t, P.H.S. Review]. Progress in Nucleic Acid Research & Molecular Biology, 45, 67–98. – reference: BednarWHolzmannKMarianBAssessing 12(S)-lipoxygenase inhibitory activity using colorectal cancer cells overexpressing the enzymeFood and Chemical Toxicology2007453508514170271361:CAS:528:DC%2BD2sXhtlaru7Y%3D – reference: WuKKLiouJYCyclooxygenase inhibitors induce colon cancer cell apoptosis Via PPARdelta -> 14-3-3epsilon pathwayMethods in Molecular Biology2009512295307193472841:CAS:528:DC%2BC3cXmt1yrtQ%3D%3D – reference: BrashARLipoxygenases: occurrence, functions, catalysis, and acquisition of substrateJournal of Biological Chemistry1999274342367923682104461221:CAS:528:DyaK1MXlsVOnsrc%3D – reference: Greene, E. R., Huang, S., Serhan, C. N., & Panigrahy, D. (2011). Regulation of inflammation in cancer by eicosanoids. Prostaglandins & Other Lipid Mediators, Epub, doi: 10.1016/j.prostaglandins.2011.08.004. – reference: ManginoMJBrountsLHarmsBHeiseCLipoxin biosynthesis in inflammatory bowel diseaseProstaglandins & Other Lipid Mediators2006791–284921:CAS:528:DC%2BD28XitVKnsrg%3D – reference: ShureiqiILippmanSMLipoxygenase modulation to reverse carcinogenesisCancer Research2001611763076312115226161:CAS:528:DC%2BD3MXmsF2jsrY%3D – reference: MichalikLDesvergneBWahliWPeroxisome-proliferator-activated receptors and cancers: complex storiesNature Reviews. Cancer2004416170147080261:CAS:528:DC%2BD2cXos12mug%3D%3D – reference: GiancottiFGRuoslahtiEIntegrin signalingScience1999285543010281032104460411:CAS:528:DyaK1MXlt1Gns7o%3D – reference: VogelsteinBFearonERHamiltonSRKernSEPreisingerACLeppertMGenetic alterations during colorectal-tumor developmentThe New England Journal of Medicine1988319952553228415971:STN:280:DyaL1czgt1aqtQ%3D%3D – reference: RicklesFRMechanisms of cancer-induced thrombosis in cancerPathophysiology of Haemostasis and Thrombosis2006351–210311016855354 – reference: KlurfeldDMBullAWFatty acids and colon cancer in experimental models. [Review]The American Journal of Clinical Nutrition1997666 Suppl1530S1538S93947111:CAS:528:DyaK2sXnslSku7w%3D – reference: W.H.O. (2005). Global action against cancer. (pp. 1–24). World Health Organisation and International Union Against Cancer. – reference: Ostrand-RosenbergSMyeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunityCancer Immunology, Immunotherapy201059101593160020414655 – reference: RadmarkOSamuelssonBMicrosomal prostaglandin E synthase-1 and 5-lipoxygenase: potential drug targets in cancerJournal of Internal Medicine20102681514204972971:CAS:528:DC%2BC3cXpsFSntLw%3D – reference: NorwoodSLiaoJHammockBDYangGYEpoxyeicosatrienoic acids and soluble epoxide hydrolase: potential therapeutic targets for inflammation and its induced carcinogenesisAmerican Journal of Translational Research201024447457207339531:CAS:528:DC%2BC3cXps1Gmtb8%3D – reference: TongWGDingXZAdrianTEThe mechanisms of lipoxygenase inhibitor-induced apoptosis in human breast cancer cellsBiochemical and Biophysical Research Communications20022964942948122001391:CAS:528:DC%2BD38XmsV2ku7c%3D – reference: YangLHuangYPortaRYanagisawaKGonzalezASegiEHost and direct antitumor effects and profound reduction in tumor metastasis with selective EP4 receptor antagonismCancer Research2006661996659672170186241:CAS:528:DC%2BD28XhtVams73P – reference: AndersonKMSeedTVosMMulshineJMengJAlrefaiW5-Lipoxygenase inhibitors reduce PC-3 cell proliferation and initiate nonnecrotic cell deathProstate199837316117397921331:CAS:528:DyaK1cXntFSnu78%3D – reference: ZuoXPengZMoussalliMJMorrisJSBroaddusRRFischerSMTargeted genetic disruption of peroxisome proliferator-activated receptor-delta and colonic tumorigenesisJournal of the National Cancer Institute200910110762767194360361:CAS:528:DC%2BD1MXmtlyit70%3D – reference: JiangJ. G.FuX. N.ChenC. L.WangD. W.Expression of cytochrome P450 arachidonic acid epoxygenase 2J2 in human tumor tissues and cell lines. [Research Support, Non-U.S. Gov’t]Ai Zheng20092829396 – reference: RaoCVRivensonASimiBReddyBSChemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compoundCancer Research199555225926678129551:CAS:528:DyaK2MXjtFyjs7Y%3D – reference: GaoXGrignonDJChbihiTZacharekAChenYQSakrWElevated 12-lipoxygenase mRNA expression correlates with advanced stage and poor differentiation of human prostate cancerUrology199546222723776249921:STN:280:DyaK2MzltV2jtA%3D%3D – reference: PozziAYanXMacias-PerezIWeiSHataANBreyerRMColon carcinoma cell growth is associated with prostaglandin E2/EP4 receptor-evoked ERK activationJournal of Biological Chemistry2004279282979729804151236631:CAS:528:DC%2BD2cXlsVCltbk%3D – reference: PatrignaniPPanaraMRGrecoAFuscoONatoliCIacobelliSBiochemical and pharmacological characterization of the cyclooxygenase activity of human blood prostaglandin endoperoxide synthasesJournal of Pharmacology and Experimental Therapeutics199427131705171279964881:CAS:528:DyaK2MXisleks70%3D – reference: BaratelliFLinYZhuLYangSCHeuze-Vourc’hNZengGProstaglandin E2 induces FOXP3 gene expression and T regulatory cell function in human CD4+ T cellsJournal of Immunology20051753148314901:CAS:528:DC%2BD2MXmtlWjtrc%3D – reference: MundRCPizatoNBonattoSNunesEAVicenziTTanhofferRDecreased tumor growth in Walker 256 tumor-bearing rats chronically supplemented with fish oil involves COX-2 and PGE2 reduction associated with apoptosis and increased peroxidationProstaglandins, Leukotrienes, and Essential Fatty Acids2007762113120172343961:CAS:528:DC%2BD2sXhvVyisrg%3D – reference: Kim, S. H., Park, Y. Y., Kim, S. W., Lee, J. S., Wang, D., & Dubois, R. N. (2011). ANGPTL4 induction by prostaglandin E2 under hypoxic conditions promotes colorectal cancer progression. Cancer Research. doi:10.1158/0008-5472.CAN-11-1262. – reference: AvisIMartinezATaulerJZudaireEMayburdAAbu-GhazalehRInhibitors of the arachidonic acid pathway and peroxisome proliferator-activated receptor ligands have superadditive effects on lung cancer growth inhibitionCancer Research2005651041814190158998091:CAS:528:DC%2BD2MXktlSmtr0%3D – reference: YoshinagaMBuchananFGDuBoisRN15-LOX-1 inhibits p21 (Cip/WAF 1) expression by enhancing MEK-ERK 1/2 signaling in colon carcinoma cellsProstaglandins & Other Lipid Mediators2004731–21111221:CAS:528:DC%2BD2cXivVCqtL4%3D – reference: KearneyPMBaigentCGodwinJHallsHEmbersonJRPatronoCDo selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trialsBMJ2006332755313021308167405581:CAS:528:DC%2BD28XntVSrtb4%3D – reference: HoweAAplinAEAlahariSKJulianoRLIntegrin signaling and cell growth controlCurrent Opinion in Cell Biology199810222023195618461:CAS:528:DyaK1cXisFyntLs%3D – reference: FeaginsLASouzaRFSpechlerSJCarcinogenesis in IBD: potential targets for the prevention of colorectal cancerNature Reviews. Gastroenterology & Hepatology2009652973051:CAS:528:DC%2BD1MXmsFWru7k%3D – reference: RicciottiEFitzGeraldGAProstaglandins and inflammationArteriosclerosis, Thrombosis, and Vascular Biology20113159861000215083451:CAS:528:DC%2BC3MXkvFantbs%3D – reference: XiaDHollaVRWangDMenterDGDuBoisRNHEF1 is a crucial mediator of the proliferative effects of prostaglandin E(2) on colon cancer cellsCancer Research2010702824831200681651:CAS:528:DC%2BC3cXltlaisw%3D%3D – reference: WatanabeKKawamoriTNakatsugiSOhtaTOhuchidaSYamamotoHRole of the prostaglandin E receptor subtype EP1 in colon carcinogenesisCancer Research1999592050935096105372801:CAS:528:DyaK1MXmvFelsrs%3D – reference: SciulliMGFilabozziPTacconelliSPadovanoRRicciottiECaponeMLPlatelet activation in patients with colorectal cancerProstaglandins, Leukotrienes, and Essential Fatty Acids20057227983156265891:CAS:528:DC%2BD2MXjvFOi – reference: Hanahan, D., & Weinberg, R. A. (2011). Hallmarks of cancer: the next generation. [Research Support, N.I.H., Extramural Review]. Cell, 144(5), 646–674, doi:10.1016/j.cell.2011.02.013. – reference: GuptaSSrivastavaMAhmadNSakamotoKBostwickDGMukhtarHLipoxygenase-5 is overexpressed in prostate adenocarcinomaCancer2001914737743112412411:CAS:528:DC%2BD3MXhsFCrtLo%3D – reference: ZeldinDCEpoxygenase pathways of arachidonic acid metabolism. [Review]Journal of Biological Chemistry2001276393605936062114519641:CAS:528:DC%2BD3MXnt1yku7o%3D – reference: GaoHWelchWJDiBonaGFWilcoxCSSympathetic nervous system and hypertension during prolonged TxA2/PGH2 receptor activation in ratsAmerican Journal of Physiology19972732 Pt 2H734H73992774901:CAS:528:DyaK2sXls12lsrg%3D – reference: BickRLCancer-associated thrombosis: focus on extended therapy with dalteparinJournal of Supportive Oncology200643115120165531361:CAS:528:DC%2BD28XkslKrsr8%3D – reference: SmithWLThe eicosanoids and their biochemical mechanisms of actionBiochemistry Journal198925923153241:CAS:528:DyaL1MXktVSktLY%3D – reference: WangDBuchananFGWangHDeySKDuBoisRNProstaglandin E2 enhances intestinal adenoma growth via activation of the Ras-mitogen-activated protein kinase cascadeCancer Research200565518221829157533801:CAS:528:DC%2BD2MXitVOjsbk%3D – reference: Nakanishi, M., Menoret, A., Tanaka, T., Miyamoto, S., Montrose, D. C., Vella, A., et al. (2011). Selective PGE2 suppression impairs colon carcinogenesis and modifies local mucosal immunity. Cancer Prevention Research (Philadelphia, Pa.). doi:10.1158/1940-6207.CAPR-11-0188. – reference: BuchananFGGordenDLMattaPShiQMatrisianLMDuBoisRNRole of beta-arrestin 1 in the metastatic progression of colorectal cancerProceedings of the National Academy of Sciences of the United States of America2006103514921497164321861:CAS:528:DC%2BD28Xhs1Gns7c%3D – reference: RigasBGoldmanISLevineLAltered eicosanoid levels in human colon cancerThe Journal of Laboratory and Clinical Medicine1993122551852382285691:STN:280:DyaK2c%2FksFWkug%3D%3D – reference: ThekenKNDengYKannonMAMillerTMPoloyacSMLeeCRActivation of the acute inflammatory response alters cytochrome P450 expression and eicosanoid metabolismDrug Metabolism and Disposition2010391222920947618 – reference: KliewerSASundsethSSJonesSABrownPJWiselyGBKobleCSFatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gammaProceedings of the National Academy of Sciences of the United States of America19979494318432391139871:CAS:528:DyaK2sXjtVyht7w%3D – reference: FelsenfeldDPChoquetDSheetzMPLigand binding regulates the directed movement of beta1 integrins on fibroblastsNature1996383659943844088377761:CAS:528:DyaK28Xmt1yktbg%3D – reference: EberhartCECoffeyRJRadhikaAGiardielloFMFerrenbachSDuBoisRNUp-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomasGastroenterology199410741183118879264681:STN:280:DyaK2M%2FhtFamsA%3D%3D – reference: KoyamaMIzutaniYGodaAEMatsuiTAHorinakaMTomosugiMHistone deacetylase inhibitors and 15-deoxy-Delta12,14-prostaglandin J2 synergistically induce apoptosisClinical Cancer Research201016823202332203716901:CAS:528:DC%2BC3cXkslSmu7o%3D – reference: PradonoPTazawaRMaemondoMTanakaMUsuiKSaijoYGene transfer of thromboxane A(2) synthase and prostaglandin I(2) synthase antithetically altered tumor angiogenesis and tumor growthCancer Research20026216366117823601:CAS:528:DC%2BD38XntV2jtg%3D%3D – reference: AntonarakisESHeathEIWalczakJRNelsonWGFedorHDe MarzoAMPhase II, randomized, placebo-controlled trial of neoadjuvant celecoxib in men with clinically localized prostate cancer: evaluation of drug-specific biomarkersJournal of Clinical Oncology2009273049864993197209081:CAS:528:DC%2BD1MXhsVCrsrzO – reference: YeYNWuWKShinVYBruceICWongBCChoCHDual inhibition of 5-LOX and COX-2 suppresses colon cancer formation promoted by cigarette smokeCarcinogenesis2005264827834156370911:CAS:528:DC%2BD2MXis1yjsLY%3D – reference: PanigrahyDKaipainenAGreeneERHuangSCytochrome P450-derived eicosanoids: the neglected pathway in cancerCancer and Metastasis Reviews2010294723735209415281:CAS:528:DC%2BC3cXhtlant7%2FJ – reference: GrauRIniguezMAFresnoMInhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanismCancer Research2004641551625171152893201:CAS:528:DC%2BD2cXmtF2mtLg%3D – reference: HarrisRCMcKannaJAAkaiYJacobsonHRDuboisRNBreyerMDCyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restrictionThe Journal of Clinical Investigation19949462504251079896091:CAS:528:DyaK2MXisFWgsrk%3D – reference: TerzicJ.GrivennikovS.KarinE.KarinM.Inflammation and colon cancerGastroenterology2010138621012114 – reference: YangVWShieldsJMHamiltonSRSpannhakeEWHubbardWCHylindLMSize-dependent increase in prostanoid levels in adenomas of patients with familial adenomatous polyposisCancer Research19985881750175395634941:CAS:528:DyaK1cXisleru78%3D – reference: Roberts, H. R., Smartt, H. J., Greenhough, A., Moore, A. E., Williams, A. C., & Paraskeva, C. (2011). Colon tumour cells increase PGE2 by regulating COX-2 and 15-PGDH to promote survival during the microenvironmental stress of glucose deprivation. Carcinogenesis. doi:10.1093/carcin/bgr210. – reference: de LevalXBenoitVDelargeJJulemontFMasereelBPirotteBPharmacological evaluation of the novel thromboxane modulator BM-567 (II/II). Effects of BM-567 on osteogenic sarcoma-cell-induced platelet aggregationProstaglandins, Leukotrienes, and Essential Fatty Acids2003681555912538091 – reference: Wasilewicz, M. P., Kolodziej, B., Bojulko, T., Kaczmarczyk, M., Sulzyc-Bielicka, V., Bielicki, D., et al. (2010). Overexpression of 5-lipoxygenase in sporadic colonic adenomas and a possible new aspect of colon carcinogenesis. [Research Support, Non-U.S. Gov’t]. International Journal of Colorectal Disease, 25(9), 1079–1085, doi:10.1007/s00384–010-0980-z. – reference: DragovichTBurrisH3rdLoehrerPVon HoffDDChowSStrattonSGemcitabine plus celecoxib in patients with advanced or metastatic pancreatic adenocarcinoma: results of a phase II trialAmerican Journal of Clinical Oncology2008312157162183916001:CAS:528:DC%2BD1cXltVGksLo%3D – reference: SenoHOshimaMIshikawaTOOshimaHTakakuKChibaTCyclooxygenase 2- and prostaglandin E(2) receptor EP(2)-dependent angiogenesis in Apc(Delta716) mouse intestinal polypsCancer Research2002622506511118097021:CAS:528:DC%2BD38XhtVyht7k%3D – reference: ParkJMKanaokaYEguchiNAritakeKGrujicSMateriAMHematopoietic prostaglandin D synthase suppresses intestinal adenomas in ApcMin/+ miceCancer Research2007673881889172831181:CAS:528:DC%2BD2sXht1yntLs%3D – reference: IharaAWadaKYonedaMFujisawaNTakahashiHNakajimaABlockade of leukotriene B4 signaling pathway induces apoptosis and suppresses cell proliferation in colon cancerJournal of Pharmacological Sciences200710312432172205951:CAS:528:DC%2BD2sXhvFGnurk%3D – reference: DannenbergAJSubbaramaiahKTargeting cyclooxygenase-2 in human neoplasia: rationale and promiseCancer Cell200346431436147063351:CAS:528:DC%2BD2cXitFKquw%3D%3D – reference: NorelXBrinkCThe quest for new cysteinyl-leukotriene and lipoxin receptors: recent cluesPharmacology and Therapeutics200410318194152512281:CAS:528:DC%2BD2cXlsFyksr8%3D – reference: BertagnolliMMEagleCJZauberAGRedstonMSolomonSDKimKCelecoxib for the prevention of sporadic colorectal adenomasThe New England Journal of Medicine20063559873884169434001:CAS:528:DC%2BD28XovFaju7Y%3D – reference: GreenhoughAWallamCAHicksDJMoorghenMWilliamsACParaskevaCThe proapoptotic BH3-only protein Bim is downregulated in a subset of colorectal cancers and is repressed by antiapoptotic COX-2/PGE(2) signalling in colorectal adenoma cellsOncogene2010292333983410203489471:CAS:528:DC%2BC3cXjvFarsb4%3D – reference: DavisBBLiuJYTancrediDJWangLSimonSIHammockBDThe anti-inflammatory effects of soluble epoxide hydrolase inhibitors are independent of leukocyte recruitmentBiochemical and Biophysical Research Communications20114103494500216830671:CAS:528:DC%2BC3MXoslCnsLo%3D – reference: ArisatoTHashiguchiTSarkerKPArimuraKAsanoMMatsuoKHighly accumulated platelet vascular endothelial growth factor in coagulant thrombotic regionJournal of Thrombosis and Haemostasis200311225892593146750941:CAS:528:DC%2BD2cXktFOlsbY%3D – reference: WangDWangHGuoYNingWKatkuriSWahliWCrosstalk between peroxisome proliferator-activated receptor delta and VEGF stimulates cancer progressionProceedings of the National Academy of Sciences of the United States of America2006103501906919074171486041:CAS:528:DC%2BD28XhtlersrjN – reference: MelstromLGBentremDJSalabatMRKennedyTJDingXZStrouchMOverexpression of 5-lipoxygenase in colon polyps and cancer and the effect of 5-LOX inhibitors in vitro and in a murine modelClinical Cancer Research2008142065256530189272921:CAS:528:DC%2BD1cXht1KgtbnF – reference: BingRJMiyatakaMRichKAHansonNWangXSlosserHDNitric oxide, prostanoids, cyclooxygenase, and angiogenesis in colon and breast cancerClinical Cancer Research200171133853392117058521:CAS:528:DC%2BD3MXptFaju7c%3D – reference: Fabre, J. E., Goulet, J. L., Riche, E., Nguyen, M., Coggins, K., Offenbacher, S., et al. (2002). Transcellular biosynthesis contributes to the production of leukotrienes during inflammatory responses in vivo. [Research Support, Non-U.S. Gov’t Research Support, U.S. Gov’t, P.H.S.]. Journal of Clinical Investigation, 109(10), 1373–1380, doi:10.1172/JCI14869. – reference: Shureiqi, I., Chen, D., Day, R. S., Zuo, X., Hochman, F. L., Ross, W. A., et al. (2010). Profiling lipoxygenase metabolism in specific steps of colorectal tumorigenesis. [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t]. Cancer Prevention Research (Philadelphia), 3(7), 829–838, doi:10.1158/1940-6207.CAPR-09-0110. – reference: CherukuriDPChenXBGouletACYoungRNHanYHeimarkRLThe EP4 receptor antagonist, L-161,982, blocks prostaglandin E2-induced signal transduction and cell proliferation in HCA-7 colon cancer cellsExperimental Cell Research20073131429692979176312911:CAS:528:DC%2BD2sXosFyktLo%3D – reference: MutohMWatanabeKKitamuraTShojiYTakahashiMKawamoriTInvolvement of prostaglandin E receptor subtype EP(4) in colon carcinogenesisCancer Research20026212832117823531:CAS:528:DC%2BD38XntlyqtA%3D%3D – reference: CaygillCPCharlettAHillMJFat, fish, fish oil and cancerBritish Journal of Cancer199674115916486794511:STN:280:DyaK283ns1entQ%3D%3D – reference: LofflerIGrunMBohmerFDRubioIRole of cAMP in the promotion of colorectal cancer cell growth by prostaglandin E2BMC Cancer2008838019099561 – reference: KawamoriTKitamuraTWatanabeKUchiyaNMaruyamaTNarumiyaSProstaglandin E receptor subtype EP(1) deficiency inhibits colon cancer developmentCarcinogenesis2005262353357155642921:CAS:528:DC%2BD2MXmsVykuw%3D%3D – reference: SonoshitaMTakakuKSasakiNSugimotoYUshikubiFNarumiyaSAcceleration of intestinal polyposis through prostaglandin receptor EP2 in Apc(Delta 716) knockout miceNature Medicine20017910481051115337091:CAS:528:DC%2BD3MXmvFOls7Y%3D – reference: GonzalezALRobertsRLMassionPPOlsonSJShyrYShappellSB15-Lipoxygenase-2 expression in benign and neoplastic lung: an immunohistochemical study and correlation with tumor grade and proliferationHuman Pathology2004357840849152575471:CAS:528:DC%2BD2cXlslOqt7c%3D – reference: RheeJSBlackMSchubertUFischerSMorgensternEHammesHPThe functional role of blood platelet components in angiogenesisThrombosis and Haemostasis2004922394402152698371:CAS:528:DC%2BD2cXmvVertb8%3D – reference: SchroderOYudinaYSabirshAZahnNHaeggstromJZSteinJ15-deoxy-Delta12,14-prostaglandin J2 inhibits the expression of microsomal prostaglandin E synthase type 2 in colon cancer cellsJournal of Lipid Research20064751071108016495511 – reference: YaqubSHenjumKMahicMJahnsenFLAandahlEMBjornbethBARegulatory T cells in colorectal cancer patients suppress anti-tumor immune activity in a COX-2 dependent mannerCancer Immunology, Immunotherapy2008576813821179629411:CAS:528:DC%2BD1cXjvFKmtbw%3D – reference: KoeberleANorthoffHWerzOCurcumin blocks prostaglandin E2 biosynthesis through direct inhibition of the microsomal prostaglandin E2 synthase-1Molecular Cancer Therapeutics20098823482355196717571:CAS:528:DC%2BD1MXpvFCmsrY%3D – reference: OhdJFNielsenCKCampbellJLandbergGLofbergHSjolanderAExpression of the leukotriene D4 receptor CysLT1, COX-2, and other cell survival factors in colorectal adenocarcinomasGastroenterology200312415770125120301:CAS:528:DC%2BD3sXot1antg%3D%3D – reference: NeedlemanPMoncadaSBuntingSVaneJRHambergMSamuelssonBIdentification of an enzyme in platelet microsomes which generates thromboxane A2 from prostaglandin endoperoxidesNature197626155615585609342941:CAS:528:DyaE28XltFymsbs%3D – reference: JuJLiuYHongJHuangMTConneyAHYangCSEffects of green tea and high-fat diet on arachidonic acid metabolism and aberrant crypt foci formation in an azoxymethane-induced colon carcinogenesis mouse modelNutrition and Cancer2003462172178146907931:CAS:528:DC%2BD2cXislSnsA%3D%3D – reference: ZamunerSRBakAWDevchandPRWallaceJLPredisposition to colorectal cancer in rats with resolved colitis: role of cyclooxygenase-2-derived prostaglandin d2American Journal of Pathology2005167512931300162514131:CAS:528:DC%2BD2MXht1agu7zK – reference: PaiRNakamuraTMoonWSTarnawskiASProstaglandins promote colon cancer cell invasion; signaling by cross-talk between two distinct growth factor receptorsThe FASEB Journal2003171216401647129581701:CAS:528:DC%2BD3sXntlSrsb4%3D – reference: ParkSWKimHSChoiMSJeongWJHeoDSKimKHThe effects of the stromal cell-derived cyclooxygenase-2 metabolite prostaglandin E2 on the proliferation of colon cancer cellsJournal of Pharmacology and Experimental Therapeutics20113362516523210629681:CAS:528:DC%2BC3MXhslWhsLk%3D – reference: CuendetMPezzutoJMThe role of cyclooxygenase and lipoxygenase in cancer chemopreventionDrug Metabolism and Drug Interactions2000171–4109157112012931:CAS:528:DC%2BD3MXis1Ggug%3D%3D – reference: DohertyGAMurrayFECyclooxygenase as a target for chemoprevention in colorectal cancer: lost cause or a concept coming of age?Expert Opinion on Therapeutic Targets2009132209218192362381:CAS:528:DC%2BD1MXksF2nuw%3D%3D – reference: CatalanoAProcopioANew aspects on the role of lipoxygenases in cancer progressionHistology and Histopathology2005203969975159449471:CAS:528:DC%2BD2MXpsFKjtL8%3D – reference: PidgeonGPKandouzMMeramAHonnKVMechanisms controlling cell cycle arrest and induction of apoptosis after 12-lipoxygenase inhibition in prostate cancer cellsCancer Research200262927212727119806741:CAS:528:DC%2BD38XjtlGrtLo%3D – reference: CarrollREBenyaRVTurgeonDKVareedSNeumanMRodriguezLPhase IIa clinical trial of curcumin for the prevention of colorectal neoplasiaCancer Prevention Research (Philadelphia, Pa.)2011433543641:CAS:528:DC%2BC3MXktl2ltbs%3D – reference: KabashimaKSajiTMurataTNagamachiMMatsuokaTSegiEThe prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gutThe Journal of Clinical Investigation20021097883893119276151:CAS:528:DC%2BD38Xis1Kju70%3D – reference: AmanoHHayashiIEndoHKitasatoHYamashinaSMaruyamaTHost prostaglandin E(2)-EP3 signaling regulates tumor-associated angiogenesis and tumor growthThe Journal of Experimental Medicine20031972221232125386611:CAS:528:DC%2BD3sXmt1Sjuw%3D%3D – reference: JuJHaoXLeeMJLambertJDLuGXiaoHA gamma-tocopherol-rich mixture of tocopherols inhibits colon inflammation and carcinogenesis in azoxymethane and dextran sulfate sodium-treated miceCancer Prevention Research (Philadelphia, Pa.)2009221431521:CAS:528:DC%2BC3cXptFKgtbY%3D – reference: ChenGGLeeJFWangSHChanUPIpPCLauWYApoptosis induced by activation of peroxisome-proliferator activated receptor-gamma is associated with Bcl-2 and NF-kappaB in human colon cancerLife Sciences2002702226312646122693901:CAS:528:DC%2BD38XkvVCitLg%3D – reference: GuptaRATanJKrauseWFGeraciMWillsonTMDeySKProstacyclin mediated activation of peroxisome proliferator-activated receptor delta in colorectal cancerProceedings of the National Academy of Sciences of the United States of America2000971327513280110878691:CAS:528:DC%2BD3cXosVOjsr8%3D – reference: DanekerGWLundSACaughmanSWStaleyCAWoodWCAnti-metastatic prostacyclins inhibit the adhesion of colon carcinoma to endothelial cells by blocking E-selectin expressionClinical & Experimental Metastasis19961432302381:CAS:528:DyaK28XkvFelsbk%3D – reference: KuntzSWenzelUDanielHComparative analysis of the effects of flavonoids on proliferation, cytotoxicity, and apoptosis in human colon cancer cell linesEuropean Journal of Nutrition1999383133142104433351:CAS:528:DyaK1MXkvVClsL4%3D – reference: Koontongkaew, S., Monthanapisut, P., & Saensuk, T. (2010). Inhibition of arachidonic acid metabolism decreases tumor cell invasion and matrix metalloproteinase expression. [Research Support, Non-U.S. Gov’t]. Prostaglandins & Other Lipid Mediators, 93(3–4), 100–108, doi:10.1016/j.prostaglandins.2010.07.002. – reference: MyungSJRerkoRMYanMPlatzerPGudaKDotsonA15-Hydroxyprostaglandin dehydrogenase is an in vivo suppressor of colon tumorigenesisProceedings of the National Academy of Sciences of the United States of America2006103321209812102168804061:CAS:528:DC%2BD28Xotlyju7Y%3D – reference: LinMSChenWCBaiXWangYDActivation of peroxisome proliferator-activated receptor gamma inhibits cell growth via apoptosis and arrest of the cell cycle in human colorectal cancerJournal of Digestive Diseases2007828288175328201:CAS:528:DC%2BD2sXnsFSlsbs%3D – reference: TanakaSTatsuguchiAFutagamiSGudisKWadaKSeoTMonocyte chemoattractant protein 1 and macrophage cyclooxygenase 2 expression in colonic adenomaGut20065515461160856941:CAS:528:DC%2BD28Xnt1yqtw%3D%3D – reference: HanahanDWeinbergRAThe hallmarks of cancerCell200010015770106479311:CAS:528:DC%2BD3cXks1CktA%3D%3D – reference: ShureiqiIWojnoKJPooreJAReddyRGMoussalliMJSpindlerSADecreased 13-S-hydroxyoctadecadienoic acid levels and 15-lipoxygenase-1 expression in human colon cancersCarcinogenesis1999201019851995105061151:CAS:528:DyaK1MXmslGktbc%3D – reference: WangDWangHBrownJDaikokuTNingWShiQCXCL1 induced by prostaglandin E2 promotes angiogenesis in colorectal cancerThe Journal of Experimental Medicine20062034941951165673911:CAS:528:DC%2BD28Xjsl2is7g%3D – reference: AggarwalBBBhardwajAAggarwalRSSeeramNPShishodiaSTakadaYRole of resveratrol in prevention and therapy of cancer: preclinical and clinical studiesAnticancer Research2004245A27832840155178851:CAS:528:DC%2BD2cXhtVSjsLrK – reference: FujinoHToyomuraKChenXBReganJWMurayamaTProstaglandin E regulates cellular migration via induction of vascular endothelial growth factor receptor-1 in HCA-7 human colon cancer cellsBiochemical Pharmacology2011813379387210707491:CAS:528:DC%2BC3cXhs1ajtrvL – reference: GalambOSiposFSpisakSGalambBKrenacsTValczGPotential biomarkers of colorectal adenoma–dysplasia–carcinoma progression: mRNA expression profiling and in situ protein detection on TMAs reveal 15 sequentially upregulated and 2 downregulated genesCellular Oncology20093111929190961471:CAS:528:DC%2BD1cXhsFSmt7bP – reference: ShimadaTKojimaKYoshiuraKHiraishiHTeranoACharacteristics of the peroxisome proliferator activated receptor gamma (PPARgamma) ligand induced apoptosis in colon cancer cellsGut2002505658664119508121:CAS:528:DC%2BD38XjvFeks7o%3D – reference: Jiang, J. G., Chen, R. J., Xiao, B., Yang, S., Wang, J. N., Wang, Y., et al. (2007). Regulation of endothelial nitric-oxide synthase activity through phosphorylation in response to epoxyeicosatrienoic acids. [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t]. Prostaglandins & Other Lipid Mediators, 82(1–4), 162–174, doi: 10.1016/j.prostaglandins.2006.08.005. – reference: GustafssonAHanssonEKressnerUNordgrenSAnderssonMLonnrothCProstanoid receptor expression in colorectal cancer related to tumor stage, differentiation and progressionActa Oncologica200746811071112179434721:CAS:528:DC%2BD2sXht1GrsrnK – reference: SheibanieAFYenJHKhayrullinaTEmigFZhangMTumaRThe proinflammatory effect of prostaglandin E2 in experimental inflammatory bowel disease is mediated through the IL-23-> IL-17 axisJournal of Immunology200717812813881471:CAS:528:DC%2BD2sXmtVKnsbg%3D – volume: 92 start-page: 394 issue: 2 year: 2004 ident: 9324_CR186 publication-title: Thrombosis and Haemostasis – volume: 25 start-page: 755 issue: 6 year: 2011 ident: 9324_CR54 publication-title: Rapid Communications in Mass Spectrometry doi: 10.1002/rcm.4926 – volume: 12 start-page: 618 issue: 8 year: 2010 ident: 9324_CR25 publication-title: Neoplasia doi: 10.1593/neo.10388 – volume: 24 start-page: 2783 issue: 5A year: 2004 ident: 9324_CR218 publication-title: Anticancer Research – ident: 9324_CR62 doi: 10.1038/onc.2011.472 – volume: 352 start-page: 1775 issue: 9142 year: 1998 ident: 9324_CR189 publication-title: Lancet doi: 10.1016/S0140-6736(98)05095-8 – volume: 175 start-page: 1483 issue: 3 year: 2005 ident: 9324_CR165 publication-title: Journal of Immunology doi: 10.4049/jimmunol.175.3.1483 – volume: 31 start-page: 19 issue: 1 year: 2009 ident: 9324_CR71 publication-title: Cellular Oncology – ident: 9324_CR30 doi: 10.1038/onc.2009.421 – volume: 310 start-page: 1504 issue: 5753 year: 2005 ident: 9324_CR101 publication-title: Science doi: 10.1126/science.1116221 – volume: 313 start-page: 2969 issue: 14 year: 2007 ident: 9324_CR104 publication-title: Experimental Cell Research doi: 10.1016/j.yexcr.2007.06.004 – ident: 9324_CR52 doi: 10.1074/jbc.271.7.3460 – volume: 117 start-page: 430 issue: 3 year: 1999 ident: 9324_CR156 publication-title: Clinical and Experimental Immunology doi: 10.1046/j.1365-2249.1999.01017.x – volume: 11 start-page: 6738 issue: 18 year: 2005 ident: 9324_CR211 publication-title: Clinical Cancer Research doi: 10.1158/1078-0432.CCR-05-0171 – volume: 10 start-page: 181 issue: 3 year: 2010 ident: 9324_CR48 publication-title: Nature Reviews. Cancer doi: 10.1038/nrc2809 – volume: 8 start-page: 82 issue: 2 year: 2007 ident: 9324_CR118 publication-title: Journal of Digestive Diseases doi: 10.1111/j.1443-9573.2007.00290.x – volume: 4 start-page: 115 issue: 3 year: 2006 ident: 9324_CR187 publication-title: Journal of Supportive Oncology – volume: 103 start-page: 24 issue: 1 year: 2007 ident: 9324_CR112 publication-title: Journal of Pharmacological Sciences doi: 10.1254/jphs.FP0060651 – volume: 24 start-page: 7320 issue: 49 year: 2005 ident: 9324_CR69 publication-title: Oncogene doi: 10.1038/sj.onc.1208883 – volume: 94 start-page: 4312 issue: 9 year: 1997 ident: 9324_CR44 publication-title: Proceedings of the National Academy of Sciences of the United States of America doi: 10.1073/pnas.94.9.4312 – volume: 14 start-page: 6525 issue: 20 year: 2008 ident: 9324_CR93 publication-title: Clinical Cancer Research doi: 10.1158/1078-0432.CCR-07-4631 – volume: 203 start-page: 941 issue: 4 year: 2006 ident: 9324_CR138 publication-title: The Journal of Experimental Medicine doi: 10.1084/jem.20052124 – volume: 100 start-page: 57 issue: 1 year: 2000 ident: 9324_CR19 publication-title: Cell doi: 10.1016/S0092-8674(00)81683-9 – volume: 94 start-page: 2504 issue: 6 year: 1994 ident: 9324_CR43 publication-title: The Journal of Clinical Investigation doi: 10.1172/JCI117620 – volume: 6 start-page: 297 issue: 5 year: 2009 ident: 9324_CR161 publication-title: Nature Reviews. Gastroenterology & Hepatology doi: 10.1038/nrgastro.2009.44 – volume: 26 start-page: 827 issue: 4 year: 2005 ident: 9324_CR193 publication-title: Carcinogenesis doi: 10.1093/carcin/bgi012 – volume: 7 start-page: 1113 issue: 11 year: 2000 ident: 9324_CR42 publication-title: Current Medicinal Chemistry doi: 10.2174/0929867003374282 – volume: 107 start-page: 1183 issue: 4 year: 1994 ident: 9324_CR77 publication-title: Gastroenterology doi: 10.1016/0016-5085(94)90246-1 – volume: 24 start-page: 985 issue: 5 year: 2003 ident: 9324_CR57 publication-title: Carcinogenesis doi: 10.1093/carcin/bgg033 – volume: 352 start-page: 1071 issue: 11 year: 2005 ident: 9324_CR15 publication-title: The New England Journal of Medicine doi: 10.1056/NEJMoa050405 – volume: 3 start-page: 401 issue: 6 year: 2003 ident: 9324_CR133 publication-title: Nature Reviews. Cancer doi: 10.1038/nrc1093 – ident: 9324_CR36 doi: 10.1111/j.1538-7836.2009.03396.x – volume: 59 start-page: 1670 issue: 12 year: 2010 ident: 9324_CR162 publication-title: Gut doi: 10.1136/gut.2009.203000 – volume: 46 start-page: 172 issue: 2 year: 2003 ident: 9324_CR219 publication-title: Nutrition and Cancer doi: 10.1207/S15327914NC4602_10 – volume: 38 start-page: 133 issue: 3 year: 1999 ident: 9324_CR215 publication-title: European Journal of Nutrition doi: 10.1007/s003940050054 – volume: 29 start-page: 276 issue: 3 year: 2005 ident: 9324_CR195 publication-title: Cancer Detection and Prevention doi: 10.1016/j.cdp.2004.12.001 – volume: 16 start-page: 2320 issue: 8 year: 2010 ident: 9324_CR117 publication-title: Clinical Cancer Research doi: 10.1158/1078-0432.CCR-09-2301 – volume: 130 start-page: 1153 issue: 5 year: 2000 ident: 9324_CR200 publication-title: Journal of Nutrition doi: 10.1093/jn/130.5.1153 – volume: 121 start-page: 1339 issue: 6 year: 2001 ident: 9324_CR149 publication-title: Gastroenterology doi: 10.1053/gast.2001.29691 – volume: 46 start-page: 1107 issue: 8 year: 2007 ident: 9324_CR67 publication-title: Acta Oncologica doi: 10.1080/02841860701403061 – volume: 55 start-page: 7695 issue: 19 year: 2007 ident: 9324_CR203 publication-title: Journal of Agricultural and Food Chemistry doi: 10.1021/jf071004r – volume: 233 start-page: 183 issue: 2 year: 2001 ident: 9324_CR131 publication-title: Annals of Surgery doi: 10.1097/00000658-200102000-00006 – volume: 28 start-page: 740 issue: 7 year: 1998 ident: 9324_CR97 publication-title: Surgery Today doi: 10.1007/BF02484622 – volume: 58 start-page: 362 issue: 2 year: 1998 ident: 9324_CR126 publication-title: Cancer Research – volume: 296 start-page: 942 issue: 4 year: 2002 ident: 9324_CR217 publication-title: Biochemical and Biophysical Research Communications doi: 10.1016/S0006-291X(02)02014-4 – volume: 79 start-page: 223 issue: 6 year: 2008 ident: 9324_CR173 publication-title: Prostaglandins, Leukotrienes, and Essential Fatty Acids doi: 10.1016/j.plefa.2008.09.024 – ident: 9324_CR4 doi: 10.1016/j.prostaglandins.2011.08.004 – volume: 352 start-page: 1092 issue: 11 year: 2005 ident: 9324_CR12 publication-title: The New England Journal of Medicine doi: 10.1056/NEJMoa050493 – volume: 70 start-page: 824 issue: 2 year: 2010 ident: 9324_CR106 publication-title: Cancer Research doi: 10.1158/0008-5472.CAN-09-2105 – ident: 9324_CR148 doi: 10.1016/S0962-8924(98)80005-6 – volume: 355 start-page: 873 issue: 9 year: 2006 ident: 9324_CR164 publication-title: The New England Journal of Medicine doi: 10.1056/NEJMoa061355 – volume: 278 start-page: 35451 issue: 37 year: 2003 ident: 9324_CR152 publication-title: Journal of Biological Chemistry doi: 10.1074/jbc.M302474200 – volume: 62 start-page: 2721 issue: 9 year: 2002 ident: 9324_CR216 publication-title: Cancer Research – volume: 25 start-page: 2303 issue: 12 year: 2004 ident: 9324_CR201 publication-title: Carcinogenesis doi: 10.1093/carcin/bgh265 – volume: 359 start-page: 235 issue: 6392 year: 1992 ident: 9324_CR27 publication-title: Nature doi: 10.1038/359235a0 – volume: 122 start-page: 518 issue: 5 year: 1993 ident: 9324_CR53 publication-title: The Journal of Laboratory and Clinical Medicine – volume: 121 start-page: 734 issue: 4 year: 2007 ident: 9324_CR159 publication-title: International Journal of Cancer doi: 10.1002/ijc.22755 – volume: 27 start-page: 1657 issue: 14 year: 2006 ident: 9324_CR13 publication-title: European Heart Journal doi: 10.1093/eurheartj/ehl053 – volume: 166 start-page: 213 year: 2005 ident: 9324_CR22 publication-title: Recent Results in Cancer Research doi: 10.1007/3-540-26980-0_14 – volume: 6 start-page: 285 issue: 3 year: 2004 ident: 9324_CR47 publication-title: Cancer Cell doi: 10.1016/j.ccr.2004.08.011 – volume: 1 start-page: 2589 issue: 12 year: 2003 ident: 9324_CR184 publication-title: Journal of Thrombosis and Haemostasis doi: 10.1046/j.1538-7836.2003.00475.x – volume: 2 start-page: 143 issue: 2 year: 2009 ident: 9324_CR207 publication-title: Cancer Prevention Research (Philadelphia, Pa.) doi: 10.1158/1940-6207.CAPR-08-0099 – volume: 27 start-page: 4986 issue: 30 year: 2009 ident: 9324_CR7 publication-title: Journal of Clinical Oncology doi: 10.1200/JCO.2009.21.9410 – volume: 261 start-page: 558 issue: 5561 year: 1976 ident: 9324_CR38 publication-title: Nature doi: 10.1038/261558a0 – volume: 383 start-page: 438 issue: 6599 year: 1996 ident: 9324_CR147 publication-title: Nature doi: 10.1038/383438a0 – volume: 69 start-page: 275 issue: 4 year: 2003 ident: 9324_CR89 publication-title: Prostaglandins, Leukotrienes, and Essential Fatty Acids doi: 10.1016/S0952-3278(03)00110-8 – volume: 519 start-page: 52 issue: 1–2 year: 2005 ident: 9324_CR141 publication-title: European Journal of Pharmacology doi: 10.1016/j.ejphar.2005.07.009 – volume: 273 start-page: H734 issue: 2 Pt 2 year: 1997 ident: 9324_CR37 publication-title: American Journal of Physiology – volume: 293 start-page: G673 issue: 4 year: 2007 ident: 9324_CR124 publication-title: American Journal of Physiology—Gastrointestinal and Liver Physiology doi: 10.1152/ajpgi.00584.2006 – volume: 434 start-page: 396 issue: 7031 year: 2005 ident: 9324_CR190 publication-title: Nature doi: 10.1038/nature03357 – volume: 47 start-page: 1071 issue: 5 year: 2006 ident: 9324_CR183 publication-title: Journal of Lipid Research doi: 10.1194/jlr.M600008-JLR200 – volume: 35 start-page: 840 issue: 7 year: 2004 ident: 9324_CR82 publication-title: Human Pathology doi: 10.1016/j.humpath.2004.04.001 – volume: 294 start-page: 1871 issue: 5548 year: 2001 ident: 9324_CR40 publication-title: Science doi: 10.1126/science.294.5548.1871 – volume: 68 start-page: 55 issue: 1 year: 2003 ident: 9324_CR192 publication-title: Prostaglandins, Leukotrienes, and Essential Fatty Acids doi: 10.1016/S0952-3278(02)00235-1 – volume: 2 start-page: 787 issue: 10 year: 2002 ident: 9324_CR175 publication-title: Nature Reviews Immunology doi: 10.1038/nri915 – volume: 23 start-page: 251 issue: 3 year: 2008 ident: 9324_CR9 publication-title: International Journal of Colorectal Disease doi: 10.1007/s00384-007-0407-7 – volume: 65 start-page: 4181 issue: 10 year: 2005 ident: 9324_CR197 publication-title: Cancer Research doi: 10.1158/0008-5472.CAN-04-3441 – volume: 580 start-page: 3368 issue: 14 year: 2006 ident: 9324_CR76 publication-title: FEBS Letters doi: 10.1016/j.febslet.2006.05.007 – volume: 94 start-page: 4318 issue: 9 year: 1997 ident: 9324_CR45 publication-title: Proceedings of the National Academy of Sciences of the United States of America doi: 10.1073/pnas.94.9.4318 – volume: 407 start-page: 249 issue: 6801 year: 2000 ident: 9324_CR132 publication-title: Nature doi: 10.1038/35025220 – volume: 271 start-page: 1705 issue: 3 year: 1994 ident: 9324_CR41 publication-title: Journal of Pharmacology and Experimental Therapeutics doi: 10.1016/S0022-3565(25)24061-7 – volume: 65 start-page: 1822 issue: 5 year: 2005 ident: 9324_CR99 publication-title: Cancer Research doi: 10.1158/0008-5472.CAN-04-3671 – volume: 103 start-page: 19069 issue: 50 year: 2006 ident: 9324_CR81 publication-title: Proceedings of the National Academy of Sciences of the United States of America doi: 10.1073/pnas.0607948103 – volume: 46 start-page: 227 issue: 2 year: 1995 ident: 9324_CR87 publication-title: Urology doi: 10.1016/S0090-4295(99)80198-8 – volume: 332 start-page: 1302 issue: 7553 year: 2006 ident: 9324_CR14 publication-title: BMJ doi: 10.1136/bmj.332.7553.1302 – volume: 2008 start-page: 931074 year: 2008 ident: 9324_CR79 publication-title: PPAR Research doi: 10.1155/2008/931074 – volume: 76 start-page: 113 issue: 2 year: 2007 ident: 9324_CR204 publication-title: Prostaglandins, Leukotrienes, and Essential Fatty Acids doi: 10.1016/j.plefa.2006.11.008 – ident: 9324_CR50 doi: 10.1016/S0079-6603(08)60867-3 – volume: 15 start-page: 5414 issue: 17 year: 2009 ident: 9324_CR121 publication-title: Clinical Cancer Research doi: 10.1158/1078-0432.CCR-08-3101 – volume: 31 start-page: 623 issue: 6 year: 2010 ident: 9324_CR125 publication-title: Tumour Biology doi: 10.1007/s13277-010-0078-9 – volume: 13 start-page: 209 issue: 2 year: 2009 ident: 9324_CR23 publication-title: Expert Opinion on Therapeutic Targets doi: 10.1517/14728220802653631 – ident: 9324_CR17 doi: 10.1007/s10555-007-9098-3 – volume: 4 start-page: 354 issue: 3 year: 2011 ident: 9324_CR212 publication-title: Cancer Prevention Research (Philadelphia, Pa.) doi: 10.1158/1940-6207.CAPR-10-0098 – volume: 58 start-page: 1750 issue: 8 year: 1998 ident: 9324_CR16 publication-title: Cancer Research – volume: 101 start-page: 762 issue: 10 year: 2009 ident: 9324_CR80 publication-title: Journal of the National Cancer Institute doi: 10.1093/jnci/djp078 – volume: 10 start-page: 6703 issue: 19 year: 2004 ident: 9324_CR86 publication-title: Clinical Cancer Research doi: 10.1158/1078-0432.CCR-04-0838 – volume: 103 start-page: 1492 issue: 5 year: 2006 ident: 9324_CR153 publication-title: Proceedings of the National Academy of Sciences of the United States of America doi: 10.1073/pnas.0510562103 – volume: 109 start-page: 883 issue: 7 year: 2002 ident: 9324_CR70 publication-title: The Journal of Clinical Investigation doi: 10.1172/JCI0214459 – volume: 178 start-page: 8138 issue: 12 year: 2007 ident: 9324_CR168 publication-title: Journal of Immunology doi: 10.4049/jimmunol.178.12.8138 – volume: 7 start-page: 3429 issue: 10 year: 2008 ident: 9324_CR122 publication-title: Molecular Cancer Therapeutics doi: 10.1158/1535-7163.MCT-08-0498 – ident: 9324_CR1 – volume: 66 start-page: 9665 issue: 19 year: 2006 ident: 9324_CR151 publication-title: Cancer Research doi: 10.1158/0008-5472.CAN-06-1271 – volume: 29 start-page: 723 issue: 4 year: 2010 ident: 9324_CR18 publication-title: Cancer and Metastasis Reviews doi: 10.1007/s10555-010-9264-x – ident: 9324_CR142 doi: 10.1016/j.prostaglandins.2006.08.005 – volume: 14 start-page: 2095 issue: 7 year: 2008 ident: 9324_CR10 publication-title: Clinical Cancer Research doi: 10.1158/1078-0432.CCR-07-4024 – volume: 4 start-page: 61 issue: 1 year: 2004 ident: 9324_CR114 publication-title: Nature Reviews. Cancer doi: 10.1038/nrc1254 – volume: 185 start-page: 7199 issue: 12 year: 2011 ident: 9324_CR177 publication-title: Journal of Immunology doi: 10.4049/jimmunol.1001876 – volume: 55 start-page: 259 issue: 2 year: 1995 ident: 9324_CR210 publication-title: Cancer Research – volume: 410 start-page: 494 issue: 3 year: 2011 ident: 9324_CR181 publication-title: Biochemical and Biophysical Research Communications doi: 10.1016/j.bbrc.2011.06.008 – volume: 26 start-page: 353 issue: 2 year: 2005 ident: 9324_CR65 publication-title: Carcinogenesis doi: 10.1093/carcin/bgh322 – volume: 74 start-page: 159 issue: 1 year: 1996 ident: 9324_CR199 publication-title: British Journal of Cancer doi: 10.1038/bjc.1996.332 – ident: 9324_CR95 doi: 10.1158/0008-5472.CAN-04-4173 – volume: 73 start-page: 111 issue: 1–2 year: 2004 ident: 9324_CR115 publication-title: Prostaglandins & Other Lipid Mediators doi: 10.1016/j.prostaglandins.2004.01.001 – volume: 63 start-page: 1748 issue: 8 year: 2003 ident: 9324_CR130 publication-title: Cancer Research – volume: 63 start-page: 2330 issue: 9 year: 2003 ident: 9324_CR134 publication-title: Cancer Research – volume: 50 start-page: 658 issue: 5 year: 2002 ident: 9324_CR120 publication-title: Gut doi: 10.1136/gut.50.5.658 – volume: 197 start-page: 221 issue: 2 year: 2003 ident: 9324_CR137 publication-title: The Journal of Experimental Medicine doi: 10.1084/jem.20021408 – volume: 66 start-page: 6649 issue: 13 year: 2006 ident: 9324_CR75 publication-title: Cancer Research doi: 10.1158/0008-5472.CAN-06-1787 – volume: 17 start-page: 1640 issue: 12 year: 2003 ident: 9324_CR154 publication-title: The FASEB Journal doi: 10.1096/fj.02-1011com – volume: 17 start-page: 109 issue: 1–4 year: 2000 ident: 9324_CR2 publication-title: Drug Metabolism and Drug Interactions doi: 10.1515/DMDI.2000.17.1-4.109 – volume: 9 start-page: 565 issue: 5 year: 2009 ident: 9324_CR174 publication-title: Current Molecular Medicine doi: 10.2174/156652409788488748 – volume: 59 start-page: 2739 issue: 11 year: 1999 ident: 9324_CR98 publication-title: Cancer Research – volume: 20 start-page: 1985 issue: 10 year: 1999 ident: 9324_CR83 publication-title: Carcinogenesis doi: 10.1093/carcin/20.10.1985 – volume: 8 start-page: 289 issue: 3 year: 2002 ident: 9324_CR100 publication-title: Nature Medicine doi: 10.1038/nm0302-289 – volume: 62 start-page: 506 issue: 2 year: 2002 ident: 9324_CR135 publication-title: Cancer Research – volume: 268 start-page: 5 issue: 1 year: 2010 ident: 9324_CR182 publication-title: Journal of Internal Medicine doi: 10.1111/j.1365-2796.2010.02246.x – volume: 61 start-page: 6307 issue: 17 year: 2001 ident: 9324_CR26 publication-title: Cancer Research – volume: 91 start-page: 737 issue: 4 year: 2001 ident: 9324_CR88 publication-title: Cancer doi: 10.1002/1097-0142(20010215)91:4<737::AID-CNCR1059>3.0.CO;2-F – volume: 14 start-page: 6859 issue: 20 year: 2006 ident: 9324_CR213 publication-title: Bioorganic & Medicinal Chemistry doi: 10.1016/j.bmc.2006.06.045 – ident: 9324_CR21 – ident: 9324_CR24 doi: 10.1002/ijc.25516 – ident: 9324_CR128 doi: 10.1093/carcin/bgr210 – volume: 10 start-page: 82 year: 2010 ident: 9324_CR58 publication-title: BMC Gastroenterology doi: 10.1186/1471-230X-10-82 – volume: 66 start-page: 1530S issue: 6 Suppl year: 1997 ident: 9324_CR3 publication-title: The American Journal of Clinical Nutrition doi: 10.1093/ajcn/66.6.1530S – ident: 9324_CR96 – volume: 71 start-page: 1627 issue: 5 year: 2011 ident: 9324_CR171 publication-title: Cancer Research doi: 10.1158/0008-5472.CAN-10-1923 – volume: 29 start-page: 790 issue: 4 year: 2008 ident: 9324_CR202 publication-title: Carcinogenesis doi: 10.1093/carcin/bgm256 – volume: 512 start-page: 295 year: 2009 ident: 9324_CR129 publication-title: Methods in Molecular Biology doi: 10.1007/978-1-60327-530-9_16 – volume: 212 start-page: 1270 issue: 4500 year: 1981 ident: 9324_CR155 publication-title: Science doi: 10.1126/science.7015512 – volume: 57 start-page: 813 issue: 6 year: 2008 ident: 9324_CR166 publication-title: Cancer Immunology, Immunotherapy doi: 10.1007/s00262-007-0417-x – ident: 9324_CR160 doi: 10.1016/j.prostaglandins.2010.07.002 – ident: 9324_CR163 doi: 10.1053/j.gastro.2010.01.058 – ident: 9324_CR92 doi: 10.1007/s00384-010-0980-z – ident: 9324_CR60 doi: 10.1158/1940-6207.CAPR-11-0188 – ident: 9324_CR11 doi: 10.1056/NEJM200011233432103 – volume: 70 start-page: 2631 issue: 22 year: 2002 ident: 9324_CR116 publication-title: Life Sciences doi: 10.1016/S0024-3205(02)01510-2 – volume: 318 start-page: 1057 issue: 3 year: 2006 ident: 9324_CR34 publication-title: Journal of Pharmacology and Experimental Therapeutics doi: 10.1124/jpet.106.101188 – volume: 265 start-page: 16737 issue: 28 year: 1990 ident: 9324_CR39 publication-title: Journal of Biological Chemistry doi: 10.1016/S0021-9258(17)44821-6 – volume: 55 start-page: 54 issue: 1 year: 2006 ident: 9324_CR169 publication-title: Gut doi: 10.1136/gut.2004.059824 – volume: 59 start-page: 1757s issue: 7 Suppl year: 1999 ident: 9324_CR143 publication-title: Cancer Research – volume: 34 start-page: 1363 issue: 5 year: 2009 ident: 9324_CR119 publication-title: International Journal of Oncology – volume: 7 start-page: 1048 issue: 9 year: 2001 ident: 9324_CR136 publication-title: Nature Medicine doi: 10.1038/nm0901-1048 – volume: 72 start-page: 79 issue: 2 year: 2005 ident: 9324_CR78 publication-title: Prostaglandins, Leukotrienes, and Essential Fatty Acids doi: 10.1016/j.plefa.2004.10.006 – volume: 97 start-page: 13275 year: 2000 ident: 9324_CR46 publication-title: Proceedings of the National Academy of Sciences of the United States of America doi: 10.1073/pnas.97.24.13275 – volume: 8 start-page: 380 year: 2008 ident: 9324_CR102 publication-title: BMC Cancer doi: 10.1186/1471-2407-8-380 – volume: 12 start-page: 313 year: 1983 ident: 9324_CR188 publication-title: Advances in Prostaglandin, Thromboxane, and Leukotriene Research – volume: 82 start-page: 135 issue: 1–4 year: 2007 ident: 9324_CR85 publication-title: Prostaglandins & Other Lipid Mediators doi: 10.1016/j.prostaglandins.2006.05.022 – volume: 62 start-page: 403 issue: 2 year: 2002 ident: 9324_CR56 publication-title: Cancer Research – volume: 25 start-page: 1671 issue: 9 year: 2004 ident: 9324_CR209 publication-title: Carcinogenesis doi: 10.1093/carcin/bgh165 – volume: 30 start-page: 42 issue: 1 year: 2008 ident: 9324_CR123 publication-title: Experimental Oncology – volume: 79 start-page: 84 issue: 1–2 year: 2006 ident: 9324_CR176 publication-title: Prostaglandins & Other Lipid Mediators doi: 10.1016/j.prostaglandins.2005.10.004 – volume: 4 start-page: 431 issue: 6 year: 2003 ident: 9324_CR6 publication-title: Cancer Cell doi: 10.1016/S1535-6108(03)00310-6 – volume: 319 start-page: 525 issue: 9 year: 1988 ident: 9324_CR31 publication-title: The New England Journal of Medicine doi: 10.1056/NEJM198809013190901 – volume: 81 start-page: 379 issue: 3 year: 2011 ident: 9324_CR150 publication-title: Biochemical Pharmacology doi: 10.1016/j.bcp.2010.11.001 – volume: 31 start-page: 986 issue: 5 year: 2011 ident: 9324_CR49 publication-title: Arteriosclerosis, Thrombosis, and Vascular Biology doi: 10.1161/ATVBAHA.110.207449 – volume: 45 start-page: 163 issue: 2 year: 2009 ident: 9324_CR167 publication-title: Journal of Clinical Biochemistry & Nutrition doi: 10.3164/jcbn.09-21 – volume: 39 start-page: 22 issue: 1 year: 2010 ident: 9324_CR179 publication-title: Drug Metabolism and Disposition doi: 10.1124/dmd.110.035287 – ident: 9324_CR108 doi: 10.1158/0008-5472.CAN-11-1262 – volume: 64 start-page: 5162 issue: 15 year: 2004 ident: 9324_CR140 publication-title: Cancer Research doi: 10.1158/0008-5472.CAN-04-0849 – volume: 8 start-page: 2348 issue: 8 year: 2009 ident: 9324_CR208 publication-title: Molecular Cancer Therapeutics doi: 10.1158/1535-7163.MCT-09-0290 – volume: 372 start-page: 249 issue: 1 year: 2008 ident: 9324_CR61 publication-title: Biochemical and Biophysical Research Communications doi: 10.1016/j.bbrc.2008.05.026 – volume: 7 start-page: 3385 issue: 11 year: 2001 ident: 9324_CR68 publication-title: Clinical Cancer Research – volume: 10 start-page: 220 issue: 2 year: 1998 ident: 9324_CR146 publication-title: Current Opinion in Cell Biology doi: 10.1016/S0955-0674(98)80144-0 – volume: 29 start-page: 3398 issue: 23 year: 2010 ident: 9324_CR127 publication-title: Oncogene doi: 10.1038/onc.2010.94 – volume: 37 start-page: 161 issue: 3 year: 1998 ident: 9324_CR196 publication-title: Prostate doi: 10.1002/(SICI)1097-0045(19981101)37:3<161::AID-PROS5>3.0.CO;2-D – volume: 46 start-page: 191 issue: 2 year: 2000 ident: 9324_CR205 publication-title: Gut doi: 10.1136/gut.46.2.191 – volume: 45 start-page: 508 issue: 3 year: 2007 ident: 9324_CR214 publication-title: Food and Chemical Toxicology doi: 10.1016/j.fct.2006.08.013 – volume: 59 start-page: 4574 issue: 18 year: 1999 ident: 9324_CR185 publication-title: Cancer Research – volume: 336 start-page: 516 issue: 2 year: 2011 ident: 9324_CR105 publication-title: Journal of Pharmacology and Experimental Therapeutics doi: 10.1124/jpet.110.173278 – volume: 267 start-page: 197 issue: 2 year: 2008 ident: 9324_CR74 publication-title: Cancer Letters doi: 10.1016/j.canlet.2008.03.004 – volume: 54 start-page: 5527 issue: 21 year: 1994 ident: 9324_CR28 publication-title: Cancer Research – volume: 324 start-page: 103 issue: 1 year: 2008 ident: 9324_CR178 publication-title: Journal of Pharmacology and Experimental Therapeutics doi: 10.1124/jpet.107.130336 – volume: 35 start-page: 103 issue: 1–2 year: 2006 ident: 9324_CR191 publication-title: Pathophysiology of Haemostasis and Thrombosis doi: 10.1159/000093551 – volume: 286 start-page: 2111 issue: 3 year: 2010 ident: 9324_CR170 publication-title: Journal of Biological Chemistry doi: 10.1074/jbc.M110.154971 – volume: 210 start-page: 41 issue: 1 year: 2004 ident: 9324_CR194 publication-title: Cancer Letters doi: 10.1016/j.canlet.2004.02.023 – volume: 59 start-page: 5093 issue: 20 year: 1999 ident: 9324_CR64 publication-title: Cancer Research – volume: 274 start-page: 23679 issue: 34 year: 1999 ident: 9324_CR110 publication-title: Journal of Biological Chemistry doi: 10.1074/jbc.274.34.23679 – volume: 195 start-page: 209 issue: 4 year: 1995 ident: 9324_CR158 publication-title: Research in Experimental Medicine (Berlin) doi: 10.1007/BF02576790 – volume: 20 start-page: 969 issue: 3 year: 2005 ident: 9324_CR29 publication-title: Histology and Histopathology – ident: 9324_CR91 doi: 10.1158/1940-6207.CAPR-09-0110 – ident: 9324_CR20 doi: 10.1016/j.cell.2011.02.013 – volume: 68 start-page: 3251 issue: 9 year: 2008 ident: 9324_CR59 publication-title: Cancer Research doi: 10.1158/0008-5472.CAN-07-6100 – volume: 5 start-page: 2716 issue: 11 year: 2006 ident: 9324_CR198 publication-title: Molecular Cancer Therapeutics doi: 10.1158/1535-7163.MCT-06-0318 – volume: 16 start-page: 4207 issue: 16 year: 2010 ident: 9324_CR206 publication-title: Clinical Cancer Research doi: 10.1158/1078-0432.CCR-10-0156 – volume: 103 start-page: 81 issue: 1 year: 2004 ident: 9324_CR111 publication-title: Pharmacology and Therapeutics doi: 10.1016/j.pharmthera.2004.05.003 – ident: 9324_CR51 doi: 10.1172/JCI14869 – volume: 67 start-page: 881 issue: 3 year: 2007 ident: 9324_CR72 publication-title: Cancer Research doi: 10.1158/0008-5472.CAN-05-3767 – volume: 311 start-page: 123 issue: 1 year: 2004 ident: 9324_CR113 publication-title: Journal of Pharmacology and Experimental Therapeutics doi: 10.1124/jpet.104.068031 – volume: 285 start-page: 1028 issue: 5430 year: 1999 ident: 9324_CR144 publication-title: Science doi: 10.1126/science.285.5430.1028 – ident: 9324_CR94 doi: 10.1016/S0163-7827(03)00049-3 – volume: 103 start-page: 12098 issue: 32 year: 2006 ident: 9324_CR66 publication-title: Proceedings of the National Academy of Sciences of the United States of America doi: 10.1073/pnas.0603235103 – volume: 89 start-page: 845 issue: 7 year: 2002 ident: 9324_CR32 publication-title: British Journal of Surgery doi: 10.1046/j.1365-2168.2002.02120.x – volume: 259 start-page: 315 issue: 2 year: 1989 ident: 9324_CR5 publication-title: Biochemistry Journal doi: 10.1042/bj2590315 – volume: 280 start-page: 3217 issue: 5 year: 2005 ident: 9324_CR55 publication-title: Journal of Biological Chemistry doi: 10.1074/jbc.M411221200 – volume: 62 start-page: 63 issue: 1 year: 2002 ident: 9324_CR139 publication-title: Cancer Research – volume: 276 start-page: 36059 issue: 39 year: 2001 ident: 9324_CR35 publication-title: Journal of Biological Chemistry doi: 10.1074/jbc.R100030200 – volume: 167 start-page: 1293 issue: 5 year: 2005 ident: 9324_CR73 publication-title: American Journal of Pathology doi: 10.1016/S0002-9440(10)61216-3 – volume: 7 start-page: 280 issue: 3 year: 2005 ident: 9324_CR84 publication-title: Neoplasia doi: 10.1593/neo.04457 – volume: 2 start-page: 447 issue: 4 year: 2010 ident: 9324_CR180 publication-title: American Journal of Translational Research – volume: 16 start-page: 619 issue: 6 year: 2004 ident: 9324_CR33 publication-title: European Journal of Gastroenterology and Hepatology doi: 10.1097/00042737-200406000-00017 – volume: 14 start-page: 230 issue: 3 year: 1996 ident: 9324_CR157 publication-title: Clinical & Experimental Metastasis doi: 10.1007/BF00053896 – volume: 62 start-page: 28 issue: 1 year: 2002 ident: 9324_CR63 publication-title: Cancer Research – volume: 279 start-page: 29797 issue: 28 year: 2004 ident: 9324_CR103 publication-title: Journal of Biological Chemistry doi: 10.1074/jbc.M313989200 – volume: 31 start-page: 157 issue: 2 year: 2008 ident: 9324_CR8 publication-title: American Journal of Clinical Oncology doi: 10.1097/COC.0b013e31815878c9 – volume: 59 start-page: 1593 issue: 10 year: 2010 ident: 9324_CR172 publication-title: Cancer Immunology, Immunotherapy doi: 10.1007/s00262-010-0855-8 – volume: 268 start-page: 233 issue: 5208 year: 1995 ident: 9324_CR145 publication-title: Science doi: 10.1126/science.7716514 – volume: 8 start-page: 3130 issue: 11 year: 2009 ident: 9324_CR107 publication-title: Molecular Cancer Therapeutics doi: 10.1158/1535-7163.MCT-09-0270 – volume: 7 start-page: 183 issue: 1 year: 2000 ident: 9324_CR109 publication-title: Oncology Reports – volume: 124 start-page: 57 issue: 1 year: 2003 ident: 9324_CR90 publication-title: Gastroenterology doi: 10.1053/gast.2003.50011 |
| SSID | ssj0007379 |
| Score | 2.294801 |
| SecondaryResourceType | review_article |
| Snippet | Arachidonic acid metabolism through cyclooxygenase (COX), lipoxygenase (LOX) and cytochrome
P
-450 epoxygenase (EPOX) pathways leads to the generation of... Arachidonic acid metabolism through cyclooxygenase (COX), lipoxygenase (LOX) and cytochrome P-450 epoxygenase (EPOX) pathways leads to the generation of... Issue Title: Bioactive Lipids in Cancer and Inflammation Arachidonic acid metabolism through cyclooxygenase (COX), lipoxygenase (LOX) and cytochrome P-450... |
| SourceID | proquest gale pubmed crossref springer |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 363 |
| SubjectTerms | Animals Arachidonic acid Biomedical and Life Sciences Biomedicine Cancer Cancer Research Care and treatment Cell death Cell Transformation, Neoplastic Cellular signal transduction Colorectal cancer Colorectal Neoplasms - enzymology Colorectal Neoplasms - immunology Colorectal Neoplasms - pathology Colorectal Neoplasms - therapy Cyclooxygenase Inhibitors - pharmacology Cyclooxygenase Inhibitors - therapeutic use Cytochrome P-450 Cytochrome P-450 Enzyme System - metabolism Development and progression Eicosanoids - immunology Eicosanoids - metabolism Humans Lipoxygenase Inhibitors - pharmacology Lipoxygenase Inhibitors - therapeutic use Lipoxygenases - metabolism Neovascularization, Pathologic - enzymology Neovascularization, Pathologic - metabolism Oncology Physiological aspects Prevention Prostaglandin-Endoperoxide Synthases - metabolism Signal Transduction Unsaturated fatty acids |
| SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1La9wwEB7aFEovpe-4SYsOhUKLiR1Z8qqXEkpCKKSnBvYm9BjDQrE38Yam9_7wztjyPgLNXqXx2p7RzMjz6RuAD0g5tjPa5NIg0gbFzHLX0C7Fe4llg6VuBiLtix_6_LL6PlfzhM3pE6xy8omDo45d4G_kR4bBcHxs8uvyKuemUVxcTR00HsIjZi5jRFc9X--3yHhHqj2m9q61MlNRczw5pxSj1sqcEpgqv90JS3ed81Z0ulMuHaLQ2TN4mtJHcTLq-zk8wPYFPL5IBfKX8PeUNNu7tltEwdAMN1BuC-47_Nv96cWiFZTxibiBCgnXRjGgtEaGDtE1gpms2RPSPwW2iusvou1IQkwM5NgLSnZJDBNc8mixhZ18BZdnpz-_neep0UIeKl2t8uBLX-rCOc3hyilZz4IrpFQeHRaoKClp9CxEdMpgEaIzoQq0JfdVbEKIUb6GvbZrcR9EE8kheOmlRFmh9vQLoSEJyksoLh5nUEzv2YbEQs7NMH7ZDX8yq8aSaiyrxt5m8GktshwpOO6b_JGVZ3l50nWDS6cM6O6Y6Mqe1CUXmmujMzjYmRmWiyu7NXq4M0qLLuwKT8Zh06Lv7dpEMxDrURZkHFuL3Q1PKQ0loIXM4M1oUutHOmZuPa1UBp8nG9tc-r_P-_beGzmAJ8M38AF-cwh7q-sbfEdJ1Mq_H5bKP3uWGyI priority: 102 providerName: ProQuest |
| Title | Eicosanoid signalling pathways in the development and progression of colorectal cancer: novel approaches for prevention/intervention |
| URI | https://link.springer.com/article/10.1007/s10555-011-9324-x https://www.ncbi.nlm.nih.gov/pubmed/22134655 https://www.proquest.com/docview/910809647 https://www.proquest.com/docview/911944103 |
| Volume | 30 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3da9swED-2FsZeRvftfgQ9DAYbZnZkyVHf0pKubLSMsUD2JPRlCAy7q1O6ve8P350j56Nsg-XBeZBOjn2nu1Pup58AXgXMsY2SKuUqBFygqFFqKlylWMtDXoVcVh2R9sWlPJ8WH2ZiFvdxtz3avS9Jdp56Y7ObEAQ0y1PMOYoUE8ddQUt3NOLpcLxyv2Uk2CNC71IK1Zcy_zTEVjC665I3YtKdImkXe8724FFMGtl4qeXHcC_UT-DBRSyLP4VfE9Rna-pm7hkBMkxHtM3otOFb87Nl85phnsf8GiDETO1Zh81a8nKwpmLEX03-D-_kyBauj1ndoATrecdDyzDFRbEQQZLv5huIyWcwPZt8OT1P4_EKqStksUidzW0uM2MkBSkjeDlyJuNc2GBCFgSmIpUcOR-MUCFz3ihXOFyI28JXznnPn8NO3dThJbDKoxuw3HIeeBGkxY9zFUpgNoLRcJhA1r9n7SL3OB2B8U2vWZNJNRpVo0k1-kcCb1YiV0vijX91fk3K0zQpcVxn4t4C_HVEb6XHZU7l5VLJBA62erqr-Xe90Xq41YpTzW0L98ah41RvtSKUJrUnwFatJEjotTo0N9QlV5h2ZjyBF0uTWj3SkBj1pBAJvO1tbD30X593_796H8DD7p_wDoRzCDuL65twhKnUwg7gfjkr8To6zQewO37_9eMEv08ml58-D7pp9RvF0R1l |
| linkProvider | Springer Nature |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VrQRcKt6kLeADCAkUNVknzhoJoQJbbWl3hVAr9ebajiOthJJts1XbO3-H_8hMXrtbid6aqz3OY8Yz48znzwBvHebYWgrpc-kcLlDkwNcZrlKM4S7MXCiyikh7PBGj4-jHSXyyBn_bvTAEq2x9YuWo08LSP_IdSWA42jb5ZXbm06FRVFxtT9CoreLAXV_iiq38vP8d1fuu398bHn0b-c2hAr6NRDT3rQlNKAKtBblmHfNkYHXAeWycdoGLMQBnYmBTp2PpAptqaSOLy08TpZm1acpx3HuwHnGU78H61-Hk56_O9ScNuR-RiScilm0Ztd6rF8eEkwt9TJki_2olEN4MB0vx8EaBtop7e49go0lY2W5tYY9hzeVP4P64Kck_hT9DtKVS58U0ZQQG0RXJN6OTji_1dcmmOcMck6ULcBLTecoqXFjNCcKKjBF3NvlevJMlOzz_xPICJVjLee5Khuk1irkGoLkzXUJrPoPjO9HCc-jlRe5eAstSdEGGG84dj5wweFmboQRmQhiJ-x4E7XdWtuE9p-M3fqsFYzOpRqFqFKlGXXnwoROZ1aQft3V-T8pT5BBwXKubfQ34dEStpXaTkErbiRQebK30tLPpmVpq3V5pxWluV4Vb41CNmylVNyk8YF0rCRJyLnfFBXUJJaa8AffgRW1S3Sv1ic1PxLEHH1sbWwz93_fdvPVB3sCD0dH4UB3uTw624GH1B74C_2xDb35-4V5hCjc3r5uJw-D0rufqP62IXEk |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1La9wwEB7SFEIvpe-4SVsdWgotZu2VJa8KpYQmS9I0oYcG9qZKsgwLxd7EG5Lc86fy7zrj1-4Gmlt8lUZ-zFPWp08A7z3W2EZJFXLlPU5Q1Cg0Oc5SrOU-zn0s85pI--hY7p8kPyZisgY33V4YglV2MbEO1Fnp6B_5QBEYjrZNDvIWFfFrd_xtdhrSAVK00NqdptFYyKG_usDZW_X1YBdV_WE4HO_9_r4ftgcMhC6RyTx0NraxjIyRFKaN4OnImYhzYb3xkReYjHM5cpk3QvnIZUa5xOFU1CZZ7lyWcRz3ATxMuYjJxdJJP9dDx2lo_ohWPJVCdQuqza49IQgxF4dYPCXh5UpKvJ0YljLjraXaOgOOn8DjtnRlO42tPYU1XzyDjaN2cf45XO-hVVWmKKcZI1iIqem-GZ15fGGuKjYtGFabLFvAlJgpMlYjxBp2EFbmjFi0KQrjnRxZ5NkXVpQowTr2c18xLLRRzLdQzcF0Cbf5Ak7uRQcvYb0oC78JLM8wGFluOfc88dLi5VyOElgTYU4eBhB131m7lgGdDuL4qxfczaQajarRpBp9GcCnXmTW0H_c1fkjKU9TaMBxnWl3OODTEcmW3kljWuROlQxga6Wnm01P9VLr9korOrxbFe6MQ7cBp9K9ewTA-lYSJAxd4ctz6hIrLH4jHsCrxqT6VxoSr58UIoDPnY0thv7v-76-80HewQZ6qP55cHy4BY_qX_E1Cmgb1udn5_4N1nJz-7b2GgZ_7ttN_wHeVF8Z |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Eicosanoid+signalling+pathways+in+the+development+and+progression+of+colorectal+cancer%3A+novel+approaches+for+prevention%2Fintervention&rft.jtitle=Cancer+and+metastasis+reviews&rft.au=Cathcart%2C+Mary-Clare&rft.au=Lysaght%2C+Joanne&rft.au=Pidgeon%2C+Graham+P&rft.date=2011-12-01&rft.pub=Springer&rft.issn=0167-7659&rft.volume=30&rft.issue=3-4&rft.spage=363&rft_id=info:doi/10.1007%2Fs10555-011-9324-x&rft.externalDocID=A712964796 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0167-7659&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0167-7659&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0167-7659&client=summon |